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Abstract

Oral-facial-digital syndrome type1 (OFD1) is an inherited disorder caused by
expression of mutant OFD1 protein and results in abnormalities in facial and limb
development and polycystic kidney disease that resembles Autosomal Dominant
Polycystic Kidney Disease (ADPKD). The similarities in renal disease
pathogenesis in patients with OFD1 and ADPKD suggest that the proteins
implicated in these diseases, OFD1 and the polycystins, respectively, function on
a common pathway in the affected cell types. This calls for an investigation to
uncover the mechanism by which OFD1 contributes to polycystic kidney disease
pathogenesis, which remains unknown. This thesis details for the first time the
assembly of a ciliary signaling microdomain containing OFD1, the polycystins,
the epidermal growth factor receptor (EGFR), and the domain organizing flotillin
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proteins in renal epithelia and cells of the oral cavity. Also, the studies presented
here provide a mechanism by which OFD1, a soluble protein, is trafficked to
primary cilia via its interaction with polycystin-1 (PC1), a ciliary membrane
protein. The presented data demonstrate the requirement of coiled coil domains
found in both OFD1 and PC1 for OFD1 interaction with PC1 and proper
localization of OFD1 to primary cilia. The composite work provides the foundation
for identifying potential molecular targets for therapeutic interventions for the
millions of individuals suffering from polycystic kidney disease worldwide.
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Chapter 1: Introduction
Modified from: Stephanie Jerman, Angela Wandinger-Ness, and Heather H.
Ward (2013). Polycystins and the Pathophysiology of ADPKD. In: Polycystic
Kidney Disease: from Bench to Bedside. 1st edition electronic book. Editors: R.L.
Bacallao and V.H. Gattone, II. Future Science Group, UK.

The number of individuals suffering from inherited, acquired, and developmental
chronic kidney disease (CKD) is on the rise worldwide [1-3]. In 2014, the National
Center for Chronic Disease Prevention and Health Promotion estimated that over
20 million people in the United States are living with some form of CKD [4]. CKD
is characterized by decreased kidney function and is associated with comorbities (such as cardiovascular disease, diabetes, anemia, and abnormalities
of mineral absorption) and increased mortality [5]. Many patients living with CKD
progress to end-stage renal disease (ESRD), ultimately requiring dialysis or
kidney transplantation. This imposes a tremendous burden on the healthcare
system accounting for over $32 billion dollars per year in healthcare expenditures
for treatment of patients with ESRD [5-7]. With the number of cases of CKD
expected to rise 5%-8% worldwide, it is clear that we need to better understand
the mechanisms contributing to CKD to tackle this growing global concern [2]

1.1 Inherited cystic kidney disease
Inherited cystic kidney diseases (ICKD) are a group of common, hereditary,
heterogeneous disorders characterized by the growth of numerous fluid-filled
1

cysts on both kidneys [3]. ICKD affect between 1:400-1:1000 individuals, which
translates to approximately 6 million people worldwide [8]. With the advancement
of modern genetics, at least 70 different genes have been found associated with
ICKD in humans [9]. ICKD result in renal cysts that originate from the epithelial
cells lining nephrons and collecting ducts of the kidney [10]. A delicate balance of
cellular proliferation and differentiation is required for normal kidney function.
Mutations causing ICKD disrupt these fundamental processes by altering normal
signaling, which in turn increases proliferation and renal epithelial apoptosis,
causes dedifferentiation and changes in cell polarity, and affects fluid secretion
and cellular adhesion. The net effect is cyst formation and expansion within the
renal tubules. While all patients with ICKD have kidney cysts, many also share
similarities in kidney pathogenesis including chronic renal interstitial inflammation
and fibrosis, renal dysmorphogenesis, and ultimate progression to ESRD.
However, the pathophysiologies of these disorders lie on a varied spectrum.
Cystic kidney disease can be inherited in an autosomal dominant, autosomal
recessive, or X-linked mode of inheritance, and vary greatly in the age in which in
the disease presents, severity of symptoms, and extent of extrarenal involvement
[11]. Symptoms of some forms of ICKD are not obvious until adulthood and
primarily only involve the kidneys; while other forms of ICKD are present from
birth or early adolescence and, in addition to cystic kidney disease, these forms
of ICKD oftentimes include extrarenal manifestations including retinal
degeneration, cardiovascular and skelatal abnormalities, and developmental
disorders. A detailed list of the different forms of ICKD is given in (Table 1). This
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dissertation will focus on two common forms of ICKD that produce a similar
kidney phenotype, Autosomal Dominant Polycystic Kidney Disease and OralFacial-Digital Syndrome Type 1. The mechanism by which mutations in different
genes that cause two distinct diseases, yet result in indistinguishable kidney
disease, remains unclear and is the focus of the studies presented here.

Table 1. Different forms of ICKD. Table lists different forms of inherited chronic
kidney diseases, their mode of inheritance, and the genes and protein products
affected in the disease.
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1.2 Autosomal Dominant Polycystic Kidney Disease and Oral-Facial-Digital
Syndrome Type 1
1.2.1 Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common
form of ICKD. ADPKD is a slowly progressive disease characterized by
cardiovascular and renal abnormalities. ADPKD is caused by mutations in the
PKD1 gene located on chromosome 16p13.3 (~85% of reported cases) or PKD2
gene located on chromosome 4q21-23 (~15% of reports cases) [10]. Mutations in
PKD1 or PKD2 result in indistinguishable disease phenotypes; however, patients
with PKD2 mutations often present later in life and have a better disease
prognosis [10]. The hallmark of ADPKD is the presence of hundreds of fluid-filled
renal cysts that can exceed two inches in diameter (Figure 1).

4

Figure 1. ADPKD kidney. ADPKD kidneys enlarge during disease progression.
Kidney weights range from a normal 150g to 4000g, and cysts of differing sizes
can be found throughout the nephrons and collecting ducts. Cysts may be filled
with clear cyst fluid, blood, or white, opaque fluid, which is an indication of
infection. ADPKD cysts increase in size during disease progression and obstruct
functional regions of the kidney. Scale bar = 1 cm, photo provided by Indiana
University Department of Pathology.
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Renal cysts form in utero and throughout a patient’s lifetime and recent imaging
studies revealed that cysts which form early in life have the most dramatic impact
on disease progression [12-14]. Cysts form in less than 1% of the 0.5-2 million
nephrons [15] and more cysts initiate from collecting ducts than the nephron
proper [14]. Given the low incidence of cyst formation (when compared to the
number of nephrons present in both kidneys), scientists have postulated that
additional genetic hits, local injury through renal ischemia, epigenetic, or other
environmental factors are necessary to initiate cyst formation. This hypothesis is
known as the “two-hit” mechanism, in which the first hit is an inherited genetic
mutation on one allele followed by a somatic mutation on the second allele. Cyst
formation likely instigates local renal fibrosis and inflammation, and the
consequent cyst expansion represents an interplay between defective signaling
cascades generated by dedifferentiated cystic epithelia, remodeling of the basal
interstitium, and signaling activation caused by ligands present in apicallysecreted cyst fluid.

Cyst expansion and concurrent renal fibrosis and interstitial inflammation
promote kidney enlargement. ADPKD kidneys enlarge at an average rate of 5%
per year [16] with cyst enlargement occurring at an average growth rate of 12%
per year [12]. However, this average rate is actually punctuated by periods of
more rapid growth as evidenced in human studies [14]. As cysts grow, they
impinge upon normal tubules and renal blood vessels, resulting in decreased
renal function and blood flow. Cysts are highly susceptible to infection and
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hemorrhage; hence additional ADPKD renal symptoms include hematuria and
urinary tract infections along with the occurrence of kidney stones, polyuria and
flank pain.

Though the renal pathology is the most striking feature of ADPKD, multiple
extrarenal manifestations do occur contributing to morbidity of ADPKD patients.
Indeed, cardiovascular complication is a leading cause of death in ADPKD
patients [17] and a majority of ADPKD patients present with hypertension even
before renal function declines [18,19]. Decreased nitric oxide production results
in increased vascular resistance, which in combination with renal factors, leads to
hypertension [18,20,21]. ADPKD patients are at greater risk for large artery and
cerebral aneurysms [17,22], likely due to aberrations in vascular smooth muscle
and endothelial cells resulting in matrix rearrangements that lead to weakening of
the vascular wall and abnormal pressure sensing [23]. Additional extrarenal
manifestations of ADPKD include mitral valve prolapse and other valve
abnormalities, inguinal and ventral hernias, occurrence of gastrointestinal
diverticuli, and formation of cysts in epithelial-lined ductal organs such as the
liver, pancreas, seminal vesicles and ovaries (among others). The
pathophysiology resulting from ADPKD is well documented; however, the links
between PKD1 and PKD2 gene mutations and the onset and progression of
ADPKD remain an area of active study in order to develop a complete picture of
disease pathogenesis.

7

Altered Kidney Function in ADPKD
ADPKD is a pleiotropic disease causing cellular, molecular, and structural
changes in the kidney. The dysregulated kidney functions that lead to cyst
formation in ADPKD can be divided into four general categories: (1) loss of cell
polarity, (2) aberrant fluid transport, (3) basement membrane and matrix
abnormalities, and (4) increased cell proliferation (discussed further in Section
1.3.3 Signaling Pathways Regulated by the Polycystins).

Maintenance of apico-basal polarity is necessary for normal tubule function. Loss
of cell polarity and altered cellular differentiation are common features observed
in cystic renal epithelial cells. For example, in normal renal epithelia the Na+-K+ATPase localizes exclusively to the basolateral plasma membrane. However, in
ADPKD cystic epithelial cells, the Na+-K+-ATPase is mislocalized to the apical
surface [17]. Additionally, in ADPKD cystic epithelia, E-cadherin is replaced with
N-cadherin, adopting a phenotype similar to that found during fetal development
[17,24]. Changes in cadherin expression may in part enable cystic epithelial cells
to preferentially associate with each other and, coupled with increased
proliferative potential, cause cysts to pouch out and wall off from the tubule of
origin (Figure 2). The secreted extracellular matrix (ECM) underlying cystic
epithelium also resembles that secreted by immature cells [24,25]. Collectively,
these studies show that cystic epithelia adopt an immature phenotype with
different cell polarity than that of mature renal epithelial cells.

8

Figure 2. Cyst growth. ADPKD renal cysts pouch out, then wall off from the
tubule from the tubule of origin. Cyst expansion causes tissue distortion and
impedes kidney function.

9

In addition to apico-basal polarity, tissue integrity is also dependent on planar cell
polarity (PCP), which is defined as the uniform organization of cells within a
plane of a mature epithelial monolayer, such that all cells are oriented in a similar
asymmetrical pattern, parallel to the basement membrane and perpendicular to
apico-basal polarity [26]. Correct PCP is crucial for proper orientation of the
mitotic spindle to ensure kidney tubular cells divide to increase tubule length
while maintaining a constant tubule diameter [26]. The contribution of
dysregulated PCP in the formation of cysts is not completely understood,
however, evidence suggests that cystic epithelia exhibit PCP defects [27]. While
loss of PCP in itself is not sufficient to initiate cyst formation, PCP dysregulation
may contribute to overall cyst expansion. Dysregulation of noncanonical
wingless/integrated (Wnt)/PCP signaling in cystic epithelia can lead to
misorientation of mitotic spindles and subsequent cell division out of the plane of
the epithelium, increasing tubule diameter and contributing to cyst expansion.
PCP is regulated, in part, by noncanonical Wnt/PCP signaling, and altered
regulation of Wnt signaling cascades is implicated in the cellular dedifferentiation
of cystic epithelia [28]. Wnt signaling cascades are critical in the regulation of
embryogenesis and the establishment and maintenance of cellular polarity and
differentiation, and thus, tight regulation of these pathways are required for
maintenance of tubular integrity [28].
Further contributing to cyst expansion in ADPKD is the observation that cystic
epithelia exhibit aberrant expression and activation of ion transporters and water
channels. Normal kidney epithelia primarily function to reabsorb water and small
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molecules from the kidney ultrafiltrate and the renal tubular reabsorption process
is accomplished through ion transporters and channels located in the epithelial
plasma membrane (Figure 3A). Cystic epithelia switch their primary function
from ion absorption to ion secretion resulting in fluid accumulation in the
intracystic region. The aberrant expression, activation, and mislocalization of
multiple ion transporters results in the secretion of fluid into the cyst lumen [29].
Secretion of water by cystic epithelia is facilitated by mislocalization and over
activation of aquaporin (AQP) water channels AQP1 and AQP2, respectively.
Cumulatively, the aberrant apical secretion of ion transporters and AQP water
channels maintain the cyst lumen and promote cyst expansion (Figure 3B).

11
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Figure 3. Altered localization and regulation of proteins and ion
transporters contribute to cyst initiation and expansion in ADPKD. Normal
renal epithelial cells primarily absorb ions and water from kidney ultrafiltrate (A).
Crosstalk between intracellular Ca2+ and cAMP regulates intracellular cAMP
levels, which are produced in part by vasopressin receptor, V2R, signaling.
Maintaining intracellular cAMP homeostasis decreases activation of the cAMPinduced K+ transporter, KCa3.1, and water channel, AQP2. Basolateral and
apical AQP1 channels regulate and maintain water reabsorption processes in
tubular epithelia. Basolateral Na+-K+-ATPase reabsorbs Na+. Cystic renal
epithelia switch their main function from ion absorption to ion secretion (B).
Decreases in intracellular Ca2+ levels, in combination with V2R activation,
increases intracellular cAMP and activates cAMP-induced KCa3.1 transporter,
thus causing an efflux of K+ and creating negative intracellular membrane
potential. Negative membrane potential causes Cl- secretion into the cyst lumen
by cAMP-activated CFTR. CFTR is absent from mature kidney tubules, but
expressed at the apical membrane in the majority of cystic epithelia. AQP1 is
enriched at the apical membrane and Na+-K+-ATPase mislocalizes to the apical
surface in cystic epithelia resulting in apical secretion of water and Na+. Loss of
β-catenin transcriptional regulation leads to aberrant expression of target genes.
E-cadherin is replaced with N-cadherin at adherens junctions, which causes the
cystic epithelia to preferentially associate with each other and form cysts.
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Renal fibrosis is concurrent with cyst expansion in ADPKD [24]. Fibrosis in
ADPKD is similar in some ways to other chronic forms of kidney disease in terms
of progression and composition [24,30], yet distinct due to changes in matrix
synthesis and cytokine secretion profiles of cystic renal epithelia [24,25].
Classically, chronic renal fibrosis is characterized by: increased synthesis and
secretion of matrix components accompanied by decreased matrix degradation;
recruitment and activation of fibroblasts and inflammatory cells to the renal
interstitium; proliferation of interstitial cells; and, impingement on renal tubules
and capillaries [24,31,32]. Cell signaling and protein expression changes in
polycystic tubular epithelial cells, along with alterations in the tubular basement
membrane, likely trigger renal fibrosis in ADPKD (Figure 4).

14

Figure 4. Fibrosis in ADPKD rat kidney. Thickening of the interstitium (*) in
three-month-old male Han:SPRD Cy/+ cystic rat kidneys (Scale bar = 20 µm).
Note the difference in renal ECM content between normal and cystic littermates.
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Cyst growth and expansion of the basement membrane and renal interstitium
causes tissue distortion through compression of renal tubules, lymphatics, and
vasculature (Figure 5). These events cause local renal ischemic injury, which in
turn promotes pathogenesis both within the kidney and to the vascular system as
a whole [33]. Since cyst expansion, inflammation, and fibrotic progression all
contribute to disease pathogenesis and renal decline, exclusive targeting of cyst
growth has not been sufficient to halt disease progression in human ADPKD. A
detailed exploration of the mechanisms contributing to cyst formation is
necessary to gain further insight into ADPKD pathophysiology.

16

Figure 5. ADPKD tubular and interstitial pathogenesis. Renal epithelial cells
undergo dedifferentiation and exhibit cellular polarity defects and increased
proliferation. Cells lose the ability to respond to PCP cues, and thus, cell division
of cystic epithelia extends tubule diameter. As cysts enlarge, cystic epithelia lose
the cuboidal/columnar phenotype and adopt a more squamoid or endothelial
appearance. Cystic epithelial cells synthesize and secrete alternative basement
membrane and ECM proteins, which causes thickening of the basement
membrane and underlying interstitial space. Expanded interstitium and cyst
growth ultimately compress surrounding vasculature, lymphatics, and renal
tubules (inset). Cytokines and growth factors recruit monocytes and fibroblasts
and subsequently promote fibroblast proliferation and activation. Myofibroblasts
also secrete matrix components and proteins involved in regulating matrix
metabolism (activators and inhibitors). Matrix metalloproteinases and protease
activators cleave and activate latent cytokines and growth factors resident within
the matrix. Aberrant signaling and response to signaling from cystic epithelia and
interstitial cells, combined with altered matrix metabolism, causes a feedback
loop that promotes cyst expansion and fibrotic progression.
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1.2.2 Oral-facial-digital syndrome type 1
Oral-facial-digital syndrome type 1 (OFD1) is an ICKD that occurs in 1:50,000
births [34]. OFD1 is caused by mutation of the OFD1 gene, also called CXORF5,
(located on the chromosome Xp22.2-Xp22.3) [35]. OFD1 is an X-linked, systemic
disease that is embryonic lethal in males [36]. Affected females exhibit
malformation of the face, oral cavity, hands and feet, as well as polycystic kidney
disease (PKD) [34,35]. Genetic links between tooth defects and kidney disease
were determined through mouse models with OFD1 mutations or conditional
knockout of OFD1. Mutant animals have disease mimicking human X-linked
OFD1 including impaired odontoblast differentiation and dentin deposition,
missing/supernumerary teeth, and cystic kidneys [36,37].
The advancement of high definition renal ultrasound scanning has shown that
PKD is much more intimately associated with OFD1 than we were previously
aware. In fact, the renal symptoms in patients with OFD1 are frequently proven to
dominate the clinical course of the disease, ultimately causing ESRD requiring
dialysis and transplantation [38]. Because of this, it is now recommended that an
OFD1 diagnosis should be suspected in families with PKD affecting only the
females. Due to the low rate of kidney transplantation, many patients with OFD1
will eventually die of renal failure. The slow progression and variability in kidney
disease severity caused by mutant OFD1 closely resembles that seen in ADPKD,
suggesting that the proteins that cause these diseases, OFD1 and the
polycystins, respectively, may function in a similar pathway. The focus of the
dissertation is to assess the similarities in protein composition and trafficking in
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the cell types affected in ADPKD and OFD1 (renal epithelia and odontoblasts,
respectively), and determining how these processes become dysregulated in
both cell types to result in similar kidney pathogenesis.

1.3 The Polycystin Proteins
ADPKD results from expression of mutant polycystin-1 (PC1) protein, encoded
by the PKD1 gene, or polycystin-2 (PC2) protein, encoded by the PKD2 gene.
Overall, the polycystins play multifunctional roles in signaling during embryonic
development, establishment of tissue polarity and differentiation, and
homeostatic regulation.

1.3.1 Structure and Function of the Polycystin Proteins
PC1 is a large multi-spanning integral membrane glycoprotein with a predicted
molecular mass of ~460 kDa. Due to its considerable size, the exact structure of
PC1 has been difficult to characterize and only recently has atomic force
microscopy of purified protein given us some insight into the domain organization
and architecture of PC1 [39]. PC1 has a long extracellular N-terminus (>3000
aa), eleven transmembrane domains (~1030 aa), and a short (~200 aa)
intracellular C-terminus (Figure 6).
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Figure 6. Structural representation of PC1 and PC2. PC1 is an integral
membrane protein with a long extracellular N-terminus, eleven transmembrane
domains, and a short cytoplasmic C-terminal tail. The N-terminus of PC1 extends
into the extracellular space and contains several structural domains, including a
signal peptide sequence, and leucine-rich repeats surrounded by two cysteinerich domains. The PC1 N-terminus contains a cell wall integrity and stress
response component (WSC domain) and a C-type lectin domain, and both are
implicated in carbohydrate binding. The PC1 N-terminus also contains a lowdensity lipoprotein (LDL) domain, 16 immunoglobulin-like PKD domains, a
receptor for egg jelly (REJ) domain, and a G protein-coupled receptor proteolytic
site (GPS). The polycystin−lipoxygenase−alphatoxin (PLAT) domain located on
the first intracellular loop may mediate membrane attachment via other protein
binding partners. PC1 contains eleven transmembrane domains; the final six
share sequence homology with PC2. The intracellular C-terminus of PC1
contains multiple protein-protein interaction domains including a JAK binding
domain, a G-protein binding domain, and a coiled coil domain. The C-terminal tail
also contains two proposed cleavage sites, a nuclear localization signal (NLS),
and a VxPx ciliary targeting motif. PC2 is an integral membrane protein with an
intracellular N-terminus, six transmembrane domains, and an intracellular Cterminus. The N-terminus of PC2 contains a VxPx ciliary targeting domain. PC2
is a member of the Ca2+-permeable channel with the ion pore predicted to reside
between the 5th and 6th transmembrane domains. The intracellular C-terminus
contains a Ca2+-binding EF hand domain, an ER retention signal, and a coiled
coil domain which interacts with the coiled coil domain of PC1 to form a
heterodimeric complex.
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PC1 has a structure similar to that of an adhesion molecule or cell surface
signaling receptor, however a ligand has not been identified for PC1. The Nterminus of PC1 contains various interaction domains, motifs, and a G proteincoupled receptor proteolytic site (GPS). The PC1 N-terminus is predicted to
sense extracellular mechanical stimuli, suggesting that PC1 acts as a
mechanosensor to relay information from the extracellular environment into the
cell to regulate cellular activities [40]. A portion of the cellular pool of PC1
undergoes cis-autoproteolysis at the GPS domain, which cleaves the N-terminal
extracellular portion from the remainder of PC1, resulting in two separate
cleavage products that remain noncovalently tethered. In the kidney, the cleaved
version of PC1 likely plays a role in signaling pathways important for cell
differentiation, whereas uncleaved PC1 appears to function primarily during
embryonic development [12]. The first cytoplasmic loop in the transmembrane
domain contains a polycystin−lipoxygenase−alphatoxin (PLAT) domain, which
likely enables PC1 association with the plasma membrane. The final six
transmembrane domains of PC1 share significant homology with the
transmembrane regions of PC2 [12]. The C-terminus of PC1 contains various
functional domains important for protein-protein interactions. Both a Janus
Kinase 2 (JAK2) and G-protein binding domain were identified in the PC1 Cterminus, suggesting that PC1 is involved in the regulation of various signaling
pathways. The C-terminal tail contains cleavage domains, producing tail
fragments that can translocate to the nucleus to modulate transcriptional
activities [41]. The first cleavage site liberates the entire C-terminus (p200), while
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further cleavage of the C-terminus produces a 150 kDa fragment and a 112
amino acid fragment (p112) of PC1 [12,42]. The PC1 C-terminus contains a
ciliary targeting VxPx motif [43] as well as a nuclear localization signal, which
highlights the complexity of this molecule. Finally, the C-terminus of PC1
contains a coiled coil (CC) domain by which it interacts with the CC domain of
PC2.

PC2 (968 aa) is an integral membrane protein with an intracellular N-terminus,
six transmembrane domains, and an intracellular C-terminus (Figure 6). PC2 has
a predicted molecular mass of ~110 kDa and is a member of the Transient
Receptor Potential (TRP) family of ion channels. PC2 is a non-selective, calcium
(Ca2+) permeable cation channel capable of modulating intracellular Ca2+ levels
[44]. Like PC1, PC2 also contains a ciliary targeting VxPx motif; however, in PC2,
this sequence is found in the N-terminus [12,27]. PC2 bears a Ca2+ channel pore
predicted to reside between the 5th and 6th transmembrane domains. The
cytoplasmic C-terminus of PC2 contains the CC PC1 interacting domain.
Although there is conflicting data, it appears that the interaction between PC2
and PC1 via the C-terminal CC domain is crucial for PC2 channel regulation [45].
Furthermore, the CC region is connected to a Ca2+-binding EF-hand domain by a
flexible acidic linker. PC2 Ca2+ channel activity is dependent on binding of
intracellular Ca2+ to the EF-hand, which then induces a conformational change in
PC2 facilitated by the flexible linker region and an influx of Ca2+ [46].
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1.3.2 Expression and Localization of the Polycystin Proteins
PC1 expression is greatest during embryonic development and decreases in
adult tissues. The subcellular localization of PC1 is spatiotemporally regulated
based on discrete functions during cell polarization (Figure 7). PC1 is important
for cell-matrix interactions and co-localizes with focal adhesions proteins,
including integrins, at early time points in cell polarization [17,24]. Later, PC1 is
important for establishing adherens junctions and desmosomes and relocates to
the forming cell-cell contacts [12]. Once, the adherens junctions are fully
established and stabilized by cytoskeletal interactions, PC1 disappears from the
lateral membrane. In fully polarized cells, PC1 localizes to the nucleus, Golgi
apparatus, cytoplasmic vesicles, and the primary cilium [12,17,47].
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Figure 7. Subcellular localization of polycystins is spatiotemporally
regulated. In normal renal epithelial cells, expression and localization of the
polycystins is spatially regulated depending on the state of cell polarization. PC1
and PC2 are highly expressed during renal development. In the mature kidney,
expression of PC1 is significantly decreased, while PC2 expression remains
high. Spatiotemporal localization of PC2 is still under investigation but PC2 is
known to reside in ER and cilia. In contrast, at early stages of cell polarization,
PC1 is found at cell-matrix interactions and associates with focal adhesion
proteins. As cells form cell-cell contacts, PC1 localizes to lateral membrane and
associates with desmosomes and adherens junction proteins. Once cells are fully
polarized, PC1 predominately localizes to the primary cilium where it forms a
complex with PC2.
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Like PC1, PC2 has multiple subcellular localizations including the endoplasmic
reticulum (ER), Golgi apparatus, apical and basolateral plasma membranes,
centrosomes, mitotic spindles, and the primary cilium [12,28] (Figure 7).
Determining how PC2 is delivered to and functions within different subcellular
regions remains an active area of study; however, certain trafficking mechanisms
and functions of PC2 have been defined. Corresponding with its role in
intracellular Ca2+ regulation, there is a large resident population of PC2 in the
ER. PC2 contains an ER retention signal in the C-terminus and is shuttled by the
PIGEA protein from the ER to the Golgi apparatus. Retention of PC2 in the transGolgi and ER is facilitated by PACS proteins (PACS1; PACS2), which actively
retrieve PC2 back to these compartments [12,27]. Although still debated, PC2
transport to the primary cilium is suggested to depend on an N-terminal sorting
signal and the expression of PC1 [27]. Both PC1 and PC2 are present in urinary
exosomes, suggesting a mechanism by which these proteins may be secreted
and contribute to signaling to nearby cells [48].
The expression and localization of the polycystins has proved complex and
dynamic during development and cell differentiation and polarization. This
complexity likely reflects the pivotal functions that the polycystins serve both at
the cellular level in the regulation of cell polarization, growth and differentiation,
and at the organ and system level in sensing and communicating signaling
events.
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1.3.3 Signaling Pathways Regulated by the Polycystins
PC1 and PC2 act as sensors of external cues that feed into multiple signaling
cascades and serve to control diverse cellular processes. The polycystins are
upstream of pathways governing cellular proliferation, differentiation, and polarity
(Figure 8). Polycystin regulation of intracellular Ca2+ levels [12], G-protein
signaling [27,49], mammalian target of rapamycin (mTOR) signaling [26,50] and
growth factor signaling cascades such as the mitogen-activated protein kinase
(MAPK)/extracellular signal-regulated kinase (ERK) [51-54] all serve to control
the rate at which cells grow and divide (Figure 8), and dysregulation of these
cellular processes are implicated in ADPKD. The polycytins are crucial for the
regulation of both canonical and noncanoical Wnt signaling pathways (Figure 8)
and aberrant regulation of Wnt signaling results in loss of cell polarity and altered
differentiation states [28,41]. Therefore, abnormal expression of PC1 or PC2
results in dysregulation of not one, but many, important cellular processes
leading to the formation and progressive enlargement of the fluid-filled cysts
characteristic of ADPKD.
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Figure 8. The polycystins regulate multiple signaling pathways. PC1 and
PC2 are sensory proteins that function upstream and downstream of signaling
pathways important for cellular proliferation, polarization, and differentiation.
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A defining feature of ADPKD is increased cell proliferation along with increased
apoptosis. Normal, full-length PC1 increases resistance to apoptosis through Gprotein-dependent activation of the PI3K/Akt pathway. Mutant PC1 expression
interferes with this normal regulation resulting in increased apoptosis of ADPKD
renal epithelia [44]. PC1 functions as a negative regulator of G-protein signaling
and this control is lost in cystic epithelia leading to increased apoptosis [27,49].

There are several known signaling pathways that contribute to increased cell
proliferation in ADPKD. Abnormal activation of a serine/threonine protein kinase,
mTOR, is one contributing factor to ADPKD disease progression. Activation of
mTOR signaling results in diverse cellular processes including cell proliferation
and protein synthesis. In ADPKD, mutant PC1 may contribute to aberrant
activation of mTOR leading to cellular proliferation [26,27]. Additionally, mTOR
activity is crucial for the phosphorylation of key components of the translation
initiation complex, resulting in assembly and initiation of protein translation and
cell growth [55]. Both PC1 and PC2 can negatively affect the protein synthesis
machinery by inhibiting activation of the eukaryotic translation initiation factors
eIF4E and eIF2a, respectively [56]. The negative regulation of eIF4E and eIF2a
imposed by PC1 and PC2 is disrupted in ADPKD resulting in increased cellular
proliferation (Figure 8).

PC1 also modulates cellular proliferation via regulation of the Janus kinase
(JAK)-signal transduction and activator of transcription (STAT) signaling cascade
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(Figure 8), a pathway that is involved in the regulation of cell cycle progression
[27]. PC1 contains a JAK binding domain, and PC1-JAK interaction causes
activation of JAK and STAT. PC1 is involved in regulating both the upstream and
downstream JAK-STAT signaling pathway to induce p21 expression and
decrease cellular proliferation. Evidence suggests that the nuclear C-terminal
fragment of PC1 is overexpressed in ADPKD, thus causing aberrant STAT
activation and this dysregulation may contribute to the proliferative phenotype of
cystic epithelia [57].

PC1 and PC2 form a receptor-channel complex in primary cilia of renal epithelial
cells to facilitate Ca2+ influx and intracellular Ca2+ homeostasis [58] (Figure 9A).
Sustained intracellular Ca2+ levels activate the PI3K/Akt pathway to inhibit B-Raf.
B-Raf is a protein kinase involved in the activation of the MAPK signaling
pathway leading to increased cellular proliferation. Since expression of mutant
PC1 or PC2 causes decreased intracellular Ca2+ concentrations in cystic
epithelia, inhibition of B-Raf is decreased, and thus contributes to increased
proliferation [44]. Crosstalk between intracellular Ca2+ levels and cAMP signaling
also impacts cellular proliferation [59]. In normal renal epithelia, cAMP inhibits
cellular proliferation by repressing the Raf-1/MEK/ERK signaling cascade. In
cystic epithelia, decreased intracellular Ca2+ levels and changes in V2R activity
cause an accumulation of intracellular cAMP and differential effects of cAMP
signaling relative to normal renal epithelia. In the disease state, loss of
intracellular Ca2+ homeostasis causes ADPKD cells to respond abnormally to
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Figure 9. Loss of ciliary signaling regulation results in aberrant cellular
proliferation in ADPKD. PC1 and PC2 form a receptor-channel complex in
primary cilia of renal epithelial cells to facilitate Ca2+ influx and intracellular Ca2+
homeostasis (A). Crosstalk between intracellular Ca2+ levels and cAMP signaling
causes inhibition of target gene transcription resulting in inhibition of cellular
proliferation. EGFR normally localizes to basolateral surface and primary cilia of
renal epithelia. In cilia, EGFR interacts with PC2 to regulate Ca2+ channel activity
from that that ciliary location. In ADPKD cystic epithelia, loss of intracellular Ca2+
homeostasis causes ADPKD cells to respond abnormally to cAMP and stimulate
cell proliferation through activation of the MEK/ERK signaling pathway (B).
Additionally, EGFR is mislocalized to the apical membrane of renal epithelia
where it can bind EGF ligand present within cyst fluid, thus causing activation
and prolonged signaling from the wrong membrane domain, which contributes to
unregulated cell proliferation in ADPKD.

32

cAMP and stimulate cell proliferation through activation of the MEK/ERK
signaling pathway [59] (Figure 9B). Treatment of ADPKD cystic cells with a Ca2+
ionophore to increase intracellular Ca2+ levels can reverse cAMP-stimulated
cellular proliferation and may offer a new approach to the treatment of ADPKD
[59].

Importantly, aberrant activation and mislocalization of the Epidermal Growth
Factor Receptor (EGFR) is a major contributor to cyst epithelial proliferation in
ADPKD. During renal development, EGFR forms heterodimers with ErbB2 at the
apical plasma membrane. As cells polarize and differentiate, ErbB2 disappears
and EGFR localizes exclusively to the basolateral membrane of normal kidney
epithelia where it’s signaling is tightly regulated (Figure 9A). In ADPKD, EGFR is
mislocalized to the apical membrane of cystic epithelial cells [17] (Figure 9B).
Missorted apical EGFR binds EGF ligand present within cyst fluid, thus causing
activation and prolonged signaling from the wrong membrane domain, which
contributes to unregulated cell proliferation in ADPKD. Furthermore, EGFR has a
unique role in primary cilia to lower the threshold for PC2 activation. In cilia, PC2
calcium channel activity is inhibited by the binding of phosphatidylinositol-4,5bisphosphate (PIP2) to PC2. Activated EGFR forms a binding site for the catalytic
enzyme phospholipase C (PLC) which cleaves PIP2 and allows for a PC2mediated Ca2+ influx [52]. In the primary cilium, PC2 co-localizes with PC1 and
other signaling molecules, such as EGFR, to form a signaling complex [52,60].
Mislocalization of EGFR in kidney epithelia causes global defects in the
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regulation of this signaling pathway (both at cell membrane and within primary
cilia) leading to increased proliferation, a major contributor to disease
progression in ADPKD.

Collectively, the polycystins are crucial to the regulation of multiple signaling
pathways controlling cellular proliferation, including mTOR, G-protein, JAKSTAT, and MAPK/ERK. PC1 and PC2 regulation begins at the plasma
membrane with the upstream activation of these cascades and continues all the
way to the nucleus to modify gene transcription and subsequent protein
synthesis. The net effect resulting from the loss of these sensor proteins is
uncontrolled proliferation, an altered differentiation state, loss of polarity, and fluid
secretion in the affected cells, which promotes cyst formation and expansion in
ADPKD

1.4 OFD1 protein
1.4.1 Expression of OFD1 protein
Oral-facial-digital syndrome type 1 results from mutations in the OFD1 gene,
which encodes OFD1 protein. OFD1 is a cytosolic protein whose expression is
tightly regulated during development. OFD1 is highly expressed during human
organogenesis in the metanephros, gonads, brain, tongue, and limbs, and at
lower levels in the liver, pancreas, heart, and lung [61,62]. Studies have shown
that OFD1 is expressed ubiquitously, albeit at lower levels, in adult tissues [62].
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1.4.2 Structure and function of the OFD1 protein
The 1011-amino acid OFD1 protein contains an N-terminal LisH motif (which
helps facilitate OFD1 interaction with microtubules) as well as five or six
predicted C-terminal CC domains that enable OFD1 protein-protein interactions.
OFD1 localizes to the centrosome during cell division, where it controls
mother/daughter centriole length [63]. OFD1 has been shown to localize to the
distal end of centrioles where it is important for distal appendage formation [63].
After the cells have finished dividing and become fully polarized, OFD1 can be
found localized to basal bodies at the base of the primary cilia [64]. OFD1 is
required for primary cilia formation and left-right axis specification [36,65]. OFD1
also localizes to centriolar satellites where autophagy-specific degradation of
OFD1 is a requisite step in ciliogenesis [66].

OFD1 interacts with the centriolar protein PCM-1 and the intraflagellar transport
protein IFT88 via OFD1 CC domains. In fact, targeting of IFT88 to the
centrosome is dependent on its interaction with OFD1 through the OFD1 second
CC domain [63,64]. The polycystins also contain CC domains, which mediate
their protein-protein interactions, and are hypothesized to interact with OFD1 via
these domains [64]. However, many important details about the interconnection
between membrane proteins (such as polycystins) and soluble proteins (such as
OFD1) that result in multi-organ diseases remain unclarified.
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1.5 Primary Cilia Link ADPKD and OFD1 Diseases
The primary cilium is an antennae-like, microtubule-based protrusion from the
apical cell surface of nearly every vertebrate cell. For decades after its discovery,
the 9+0 primary cilia was largely ignored by scientists; believed to be a relic left
over from our evolutionary past. However, recent studies have shown that
mechanical bending of primary cilia in cultures kidney cells resulted in an
increase in intracellular calcium that propagated out to neighboring cells [67].
These observations led to a renewed interest in this once ignored cellular
organelle that has since produced evidence that primary cilia are crucial in a
number of cellular processes, both during development and later for maintaining
cellular homeostasis. The primary cilium is crucial during development where it
plays a major role in Hedgehog and Wnt signaling cascades [37,68]. Primary cilia
sense changes in the extracellular environment and relay extracellular cues into
the cell. The primary cilium houses many important signaling proteins and
functions as a signaling hub. The primary cilia contain ICKD proteins including
PC1 and PC2. Not surprisingly, a multitude of human diseases caused by
defects in ciliary proteins, termed ciliopathies, have been identified. ADPKD was
the founding member of an ever-expanding list human ciliopathies, including
OFD1.

Research into the primary cilium over the last decade has revealed some striking
similarities in the mechanism whereby odontoblasts and renal epithelial cells
respond to external stimuli. The function of the primary cilium of odontoblasts is
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believed to closely mimic the sensory function of cilia in renal epithelial cells [6971]. It is hypothesized that, in both cell types, the primary cilium is the critical link
between extracellular mechanical stimuli and initiation of an intracellular signaling
cascade in response. The primary cilium of an odontoblast is crucial for sensing
the extracellular environment to regulate the formation of dentin and in tooth pain
transmission. Similarly, the primary cilium in renal epithelial cells functions as a
mechanosensor of external fluid flow to regulate cell differentiation and
polarization. Odontoblasts and renal epithelial cells both display voltage-gated
calcium channels and mechanosensitive potassium channels in their plasma
membranes which are believed to act with primary cilia to transmit external
messages into the cell [69,70]. Thus, in these two very different cell types the
primary cilium serves a similar function for sensing and communicating changes
in the external environment. Furthermore, ciliary protein defects often result in
multi-organ involvement. This evidence highlights the importance of elucidating
the commonalities between renal epithelia and cells of the oral cavity in order to
gain a molecular understanding for how and why these diseases, such as OFD1
and ADPKD, result in multi-organ pathologies.

1.6 Overall Hypothesis
Many proteins associated with craniofacial and cystic kidney disease localize to
and function within the primary cilium, including OFD1 [72,73] and the
polycystins. The role of OFD1 in oral and renal pathologies is likely linked to its
conserved expression and function, along with the polycystins, in the cilia of
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odontoblasts and renal epithelia though the mechanistic underpinnings are
unclear [37,64,74]. The polycystins and OFD1 are likely part of a conserved
ciliary signaling microdomain in renal epithelia and cells of the oral cavity; which
would explain the overlapping PKD patholodies observed in ADPKD and OFD1
diseases. Based on the available literature, the overall hypothesis for the
dissertation is that OFD1 is trafficked to the primary cilium in odontoblast
cells using a conserved trafficking mechanism where it is assembled into
distinct microdomains constituted of signaling and lipid scaffolding
proteins.

Specific Aims
Specific Aim 1: To characterize the ciliary signaling domains shared between
kidney epithelial cells and cells of the oral cavity.
Specific Aim 2: To determine the interdependence of OFD1 and PC1 for OFD1
trafficking to primary cilia.

1.7 Significance
Findings over the last eight years show that many of the proteins associated with
craniofacial and cystic kidney disease localize to and function in the primary
cilium and when defective result in significant developmental defects and multiorgan failure [72,73]. Although the connection between OFD1 and renal disease
has been known for many years [62], there has yet to be a conclusive
investigation into the shared mechanisms in different cell types affected in these
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diseases; cells of the oral cavity and renal epithelia, respectively. Past studies
have focused mainly on the role of OFD1 at the centrosome and basal bodies
and have shown that OFD1 is required for ciliogensis; however, OFD1 also
localizes to the shaft of primary cilia, suggesting that OFD1 has a role beyond
ciliogenesis and performs a distinct function in the primary cilium [64]. However,
it is unknown how OFD1 arrives at the primary cilium or whether OFD1 is
organized into ciliary microdomains with proteins implicated in PKD, either of
which could explain similarities in disease pathology.

This research is significant because it, for the first time, probed for
interconnections in the ciliary transport and functional assembly of OFD1 and the
polycystins in specialized ciliary membrane domains. Innovative technologies
were used to bridge gaps in the mechanistic details of how defects in cells of the
oral cavity and kidney are related, leading to multi-organ disease. Characterizing
this pathway may in the long term identify new therapeutic interventions for
enhancing protein function in and/or targeting to the cilia.
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Chapter 2: Materials and Methods

2.1 Cells and Reagents
Dental pulp-derived odontoblasts were used as representative neural crest
derived cells from the oral cavity. The previously characterized MO6-G3
immortalized mouse dental pulp-derived odontoblast cell line was used as
described [75]. MO6-G3 cells were grown in alpha-MEM supplemented with 10%
FCS, 100 units/ml penicillin and streptomycin, 50 µg/ml ascorbic acid at 33°C in a
humidified atmosphere of 95% air and 5% CO2, with media changes every two
days. The previously characterized PKD Q4004X PKD cells [76] were a
generous gift from Dr. Robert Bacallao (Indiana University School of Medicine,
Indianapolis, IN). Primary human cell line 46M06 was obtained from renal cysts
of an ADPKD kidney. Human cell lines from renal cortical tubular epithelia
(RCTE) were immortalized and cultured as previously described (Nauli, 2006,
Ward 2011}. Renal proximal tubule cells (RPTEC) were purchased from Lonza
(Walkersville, MD) and cultured using RCTE conditions. Cell culture reagents
were purchased from Invitrogen/Gibco (Carlsbad, CA). Rabbit pAb directed
against PC1 NM005 raised by immunizing rabbits with a distal carboxy-terminal
fragment of polycystin-1 (amino acids 4070-4302) (Roitbak, 2004); rabbit antiPC1 NM002 and NM032 raised in rabbits immunized with a peptide
corresponding to aa 3633–3645 of human PC1, and with an N-terminal cysteine
(CKRLHPDEDDTLVE; Suzanna Horvath, California Institute of Technology,
Pasadena, CA). The peptide was conjugated to keyhole limpet hemocyanin using
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benzoquinone and was used to immunize rabbits NM002 and NM032 (Covance,
Denver, PA). For affinity purification, the same peptide was conjugated to
Sulfalink gel (#20401; Pierce) according to the manufacturer’s instructions (1 mg
peptide/1 ml resin bed volume). Ten ml NM002 serum was incubated with 5 ml
resin and washed to remove unbound immunoglobulin and serum proteins.
Bound immunoglobulin was eluted with 0.1 M glycine (pH 2.5), immediately
neutralized with Tris base, and used for immunoblotting and immunostaining
experiments at a concentration of 10 μg/ml. (Ward, 2011); rabbit pAb against
polycystin-1 (PC1-FP-LRR antibody) was generated against a fusion protein
containing residues 27 to 360 of human polycystin-1 [77]. Primary antibodies
were purchased from the following vendors: mouse mAb directed against
acetylated α-tubulin (Sigma-Aldrich T7451, St. Louis, MO); rabbit pAb directed
against α/ß-tubulin (Cell Signaling Technology #2148, Danvers, MA); mouse
mAb anti-actin, clone C4 (Millipore #MAB1501, Temecula, CA); goat pAb
directed against Lamin B (Santa Cruz sc-6217, Santa Cruz, CA); mouse mAb
anti-polycystin-1 (Santa Cruz Biotechnology sc-130554, Santa Cruz, CA); mouse
mAb anti-CD16 (Santa Cruz Biotechnology sc-20052, Santa Cruz, CA); mouse
mAb anti-Giantin (AbCam ab37266, Cambridge, MA); mouse mAb anti-GST
(Santa Cruz Biotechnology sc-138, Santa Cruz, CA); rabbit pAb anti-polycystin-2
(AbCam ab78622, Cambridge, MA); rabbit pAb anti-polycystin-2 (Santa Cruz
Biotechnology sc25749, Santa Cruz, CA); rabbit pAb anti-EGFR (GeneTex
GTX121919, Irvine, CA); rabbit pAb anti-EGFR (Santa Cruz Biotechnology sc-03,
Santa Cruz, CA); rabbit pAb anti-ErbB2 (US Biological E3451-27, Swampscott,
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MA); rabbit mAb anti-ErbB2 (Epitomics #2064-1, Burlingame, CA); rabbit pAb
anti-OFD1 (Novus Biologicals NBP1-89355, Littleton, CO); goat pAb anti-OFD1
(Santa Cruz Biotechnology sc-168837, Santa Cruz, CA); rabbit pAb anti-Flotillin1 (AbCam ab-50671, Cambridge, MA); mouse mAb anti-Flotillin-1 (BD
Transduction Laboratories 610820, San Jose, CA); rabbit mAb anti-Flotillin-2
(Cell Signaling Technology #3436, Boston, MA); mouse mAb anti-Flotillin-2 (BD
Transduction Laboratories 610383, San Jose, CA). Secondary antibodies were
purchased from the following vendors: ECL Anti-Rabbit IgG-HRP (GE Healthcare
NA934V, Little Chalfont, Buckinghamshire); ECL Anti-Mouse IgG-HRP (GE
Healthcare NA931V, Little Chalfont, Buckinghamshire); donkey anti-goat IgGHRP (Santa Cruz sc-2020, Santa Cruz, CA); Rabbit TrueBlot ULTRA: Anti-Rabbit
Ig HRP (eBioscience 18-8816, San Diego, CA); Mouse TrueBlot ULTRA: AntiMouse Ig HRP (eBioscience 18-8817, San Diego, CA); mouse IgG2a, κ mouse
isotype control (Sigma-Aldrich M5409, Saint Louis, MO) normal rabbit IgG
isotype control (Santa Cruz Biotechnology sc2027, Santa Cruz, CA). The
following fluorophore-conjugated secondary antibodies (Alexa Fluor dyes) were
used for immunofluorescence assays: Alexa Fluor 488 Donkey Anti-Mouse IgG
(Invitrogen A-21202, Grand Island, NY); Alexa Fluor 488 Donkey Anti-Rabbit IgG
(Invitrogen A-21206, Grand Island, NY); Alexa Fluor 555 Donkey Anti-Mouse IgG
(Invitrogen A-31570, Grand Island, NY); Alexa Fluor 488 Donkey Anti-Goat IgG
(Invitrogen A-11055, Grand Island, NY); Alexa Fluor 555 Donkey Anti-Rabbit IgG
(Invitrogen A-31572, Grand Island, NY); Alexa Fluor 647 Donkey Anti-Mouse IgG
(Invitrogen A-31571, Grand Island, NY); Alexa Fluor 647 Donkey Anti-Rabbit IgG
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(Invitrogen A-31573, Grand Island, NY); Alexa Fluor 647 Donkey Anti-Goat IgG
(Invitrogen A-21082, Grand Island, NY).

2.2 Immunofluorescence Staining
For ciliary immunolocalization experiments, cells were grown on glass coverslips
or 0.4 µm ﬁlter supports (Falcon-BD 353090, Franklin Lakes, NJ) for 4-6 days
post-confluence and fixed with 3% paraformaldehyde (PFA) and processed for
immunostaining as previously described [47]. Briefly, cells were permeabilized
using 0.1% Triton-X 100 in 0.2% cold fish gelatin (blocking agent), and primary
and secondary antibody incubations were performed in a humidified chamber at
37°C. Cells were labeled with antibodies directed against OFD1, EGFR, ErbB2,
PC1, PC2, flotillin-1, or CD16. Cells were co-labeled with anti-acetylated αtubulin or anti-α/β-tubulin to identify primary cilia. Controls for specificity and
auto-fluorescence included staining with secondary antibodies alone. Ciliary
colocalization of proteins with acetylated α-tubulin or α/β- tubulin was defined as
exhibiting colocalization of the two signals across at least two pixels within the
cilium as imaged in the confocal Z-stack data. Confocal immunofluorescence
images were collected using a Zeiss LSM510 or Zeiss LSM 510-META laserscanning confocal microscope (Carl Zeiss, Thornwood, NY) with 40x, 1.3
numerical aperture (NA) or 63x, 1.4 NA oil immersion objectives. LSM 510 Image
Acquisition software (Carl Zeiss) was used to acquire images. Confocal Z-stacks
were processed with the Zeiss Image Browser or Voxx2 (provided freely for
noncommercial use by the Indiana Center for Biological Microscopy,
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Indianapolis, IN, www.nephrology.iupui.edu/imaging/voxx/index.htm), and
assembled using Adobe Photoshop and Illustrator (Adobe, San Jose, CA).
Quantification was performed by importing z-stack images (all taken at identical
settings) into SlideBook software (Intelligent Imaging) and creating a ciliary mask
based on acetylated α-tubulin or α/β-tubulin staining. Ciliary protein (OFD1, PC1,
PC2, flotillin-1, EGFR, GFP-OFD1, and CD16) staining intensities within the
ciliary mask were quantified and normalized based on ciliary volume. At least 30100 cilia were quantified from multiple experiments.
Movies were generated using the movie maker feature in Voxx2 software, and
converted to .avi and .mpg file formats using QuickTime Player (Apple,
Cupertino, CA) and TMPGEnc (Pegasys, Tokyo, Japan), respectively.

2.3 Proximity Ligation Assay (PLA)
PCR-based visualization was performed using Duolink II Rabbit/Mouse Red Kit
(Olink Bioscience #92101) following manufacturer’s instructions (Figure 10).
Cells were grown on coverslips 5 days post-confluency to allow for ciliogenesis
and then fixed with 3%PFA. Primary antibodies used were: rabbit anti-EGFR
(GeneTex GTX121919, Irvine, CA) and anti-polycystin-1 (Santa Cruz
Biotechnology sc-130554, Santa Cruz, CA).
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Figure 10. Duolink proximity based ligation assay. RCTE and MO6-G3 cells
were plated on glass coverslips and grown 4-6 days post-confluency to allow for
ciliogenesis (A). Cells were then fixed with 3% PFA and labeled with the following
primary antibodies: rabbit anti-EGFR and mouse anti-PC1 (B). Secondary antirabbit and anti-mouse proximity ligation probe antibodies bound to specific PCR
primers were added (C). When two proteins reside within <40nm, a rolling circle
amplification reaction occurs (D) that integrates a fluorescent probe (E), which
can be visualized using confocal microscopy (F).
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2.4 Immunoprecipitations
Cells were grown 3-5 days post-confluency to ensure cilial formation. Cells were
washed in PBS and lysed on ice in lysis buffer (0.5% NP40, 10 mM Tris-HCL pH
7.4, 150 mM NaCl, 5 mM EDTA, 50 mM NaF, 1mM Na3VO4, 60 mM n-octyl-β-Dglucopyranosid (AppliChem A1010, Saint Louis, MO), supplemented with
protease inhibitor cocktail (Calbiochem/EMD Chemicals, Gibbstown, NJ).
Lysates were precleared by centrifugation at 10,000 rpm in an Eppendorf
microcentrifuge for 10 minutes and pretreated with protein G Sepharose or
protein A Sepharose (Amersham Biosciences/GE Healthcare, Piscataway, NJ);
500 µg of total protein was used for immunoprecipitations. 500 µg cell lysate/40
µg protein A Sepharose or protein G Sepharose at 4˚C for 3 hours on a rotator.
Precleared lystate supernatant was transferred to a clean microfuge tube and
incubated with 1-3 µg of antibody directed against specified protein at 4˚C for 2
hours with gentle rotation. Antibody complexes were recovered by incubation
with Protein G or Protein A Sepharose beads at 4˚C overnight. The
immunoprecipitates were washed three times in lysis buffer and supplemented
with SDS-PAGE loading buffer, heated for 5 minutes at 94˚C, and resolved by
SDS gel electrophoresis.

2.5 Deciliation Assay
Renal epithelial cells were deciliated using 1.5 mM dibucaine-HCl for 5 minutes
or 5 mM dibucaine-HCL in culture media for 5 minutes or 15 minutes, both of
which rapidly and selectively caused the intact shedding of primary cilia from the
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cell surface as was observed previously for IMCD3 cells [78,79]. Dibucaine
treatment conditions were optimized by testing different concentrations and
treatment times with the goal of promoting cilial release without cell detachment.
A stock solution of dibucaine HCl (25 mM) was diluted to 1.5 mM or 5 mM in
Tyrodes balanced salt solution. RCTE and MO6-G3 cells were grown on 60mM
collagen-1 coated cell culture dishes for 5-6 days post-confluency to allow for
ciliogenesis. Media was aspirated and cells were washed three times in PBS+
(PBS with 1 mM Ca2+ and 1 mM Mg+ added). Dibucaine was then added for 5-15
minutes with agitation causing deciliation. Tyrodes/dibucaine-HCl solution
containing the cilia were then collected and centrifuged at 850 gmax for 10 minutes
to collect cell bodies. The supernatant containing the ciliary fraction was collected
and cilia were harvested by centrifugation at 28,000 gmax for 30 minutes.
Supernatant was removed and pellet containing ciliary fraction was resuspended
using 30 µl of lysis buffer and run on a SDS-PAGE gel.

2.6 Transient transfections with flotillin-2-GFP or GFP-OFD1
Flotillin-2–EGFP (where EGFP stands for enhanced green fluorescent protein)
encoding full-length rat flottilin-2 fused in frame at the C-terminus to EGFP was
provided by Dr. Ritva Tikkanen [80]. GFP-OFD1 encoding full-length OFD1 fused
in frame at the N-terminus to pEGFP-N1 vector [81] was provided by Dr. Andrew
Fry. Cells were plated at confluency on filter supports and cultured as described
above 4-6 days post-confluency to ensure ciliogenesis. Transfections were
performed by electroporation (iPoration-Primax Biosciences, Menlo Park, CA)
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according to the manufacturer’s instructions. The iPorator (Primax Biosciences,
Inc.) yields 40-60% transfection efficiency in both cell types (Figure 11). Flotillin2-GFP and GFP-OFD1 transfection efficiency of ~40% was consistently
observed. Cells were fixed with 3% PFA 16 h post-transfection, and viewed
directly or processed for co-immunostaining.
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Figure 11. iPoration yields high transfection efficiencies for plasmid
expression vectors and siRNA in post-confluent, polarized MO6-G3 and
RCTE cells. MO6-G3 odontoblasts are an inherently more difficult cell line to
transfect. This problem is compounded further by the necessity to transfect these
cells after they are 100% confluent and have a completely polarized phenotype
with very tight cell-cell contacts. With iPoration transfection efficiencies were 6070% for FITC-labeled siRNA and 40-60% for flotillin-2-GFP in both MO6-G3 and
RCTE cell types. As a comparison, traditional lipofection using Lipofectamine
2000 (Life Technologies) resulted in transfection efficiencies that were
consistently <10%.
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2.7 iDimerize-CD16.7-PC1-PC1 constructs
Purple: DmrD domain
Yellow: Preferred Furin cleavage site R-x-K-R
Red: CD16 without leader
Italics : CD7
Underline: PC1 WT
MATGSRTSLLLAFGLLCLPWLQEGSASRGVQVETISPGDGRTFPKRGQTCVVH
YTGMLEDGKKMDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTIS
PDYAYGATGHPGIIPPHATLVFDVELLKLETRGVQVETISPGDGRTFPKRGQTC
VVHYTGMLEDGKKMDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAK
LTISPDYAYGATGHPGIIPPHATLVFDVELLKLETRGVQVETISPGDGRTFPKRG
QTCVVHYTGMLEDGKKMDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQ
RAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLETRGVQVETISPGDGRTFP
KRGQTCVVHYTGMLEDGKKMDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMS
VGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLETSARNRQKRDLPKAV
VFLEPQWYSVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATV
NDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNT
ALHKVTYLQNGKDRKYFHHNSDFHIPKATLKDSGSYFCRGLVGSKNVSSETVNI
TITQGLAVSTISSFSPPGADPPRASALPAPPTGSALPDPQTASALPDPPAASALP
AALAVISFLLGLGLGVACVLARTRSQLDGLSVSLGRLGTRCEPEPSRLQAVFEA
LLTQFDRLNQATEDVYQLEQQLHSLQGRRSSRAPAGSSRGPSPGLRPALPSRL
ARASRGVDLATGPSRTPLRAKNKVHPSST
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The iDimerize-PC1-CD16.7-PC1-WT and iDimerize-CD16.7-PC1-359 (deletion of
last 20 amino acids of the PC1 C-terminus) constructs were prepared under
contract with Clonetech Laboratories Inc. (Mountain View, CA 94043). Each
vector was fully sequenced by the University of New Mexico Health Sciences
Center (UNM HSC) Research Services.

2.8 Transient co-transfections with GFP-OFD1 and either CD16.7-PC1
tripartite fusion proteins or iDimerize-CD16.7-PC1 constructs
GFP-OFD1 encoding full-length OFD1 fused in frame at the N-terminus to
pEGFP-N1 vector [81] was provided by Dr. Andrew Fry. CD16.7-PC1-WT
(CD16.7-PKD1(115-226)) and CD16.7-PC1-L152P (CD16.7-PKD1(115-226)
L152P) described in Vandorpe et al., 2001 [82] were a generous gift from Dr.
Seth Alper. CD16.7-PC1-WT tail (total length 379 amino acids) and CD16.7-PC1359 (total length 359 amino acids- lacking the last 20 amino acids
(ATGPSRTPLRAKNNKVHPSST) of the PC1 tail) fusion proteins used for the
cloning of iDimerize-CD16.7-PC1 constructs described in Ward et al., 2011 and
Vandorpe et al., 2001 [43,82]. Cells were plated at confluency on filter supports
and cultured as described above 4-6 days post-confluency to ensure
ciliogenesis. Transfections were performed by electroporation (iPoration-Primax
Biosceinces, Menlo Park, CA) according to the manufacturer’s instructions. The
iPorator (Primax Biosciences, Inc.) yields ~40% transfection efficiency in RCTE
cells [60]. GFP-OFD1 and iDimerize-CD16.7-PC1-WT, iDimerize-CD16.7-PC1359, CD16.7-PC1-WT, or CD16.7-PC1-L152P co-transfection efficiency of ~40%
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was consistently observed. 16 hours post-transfection cells were either
processed for Golgi Lock assay or (iDimerize-PC1-CD16.7 constructs were
treated +/- solubilizer) fixed with 3% PFA and viewed directly or processed for coimmunostaining. For iDimerize-CD16.7-PC1 constructs, 16 hours posttransfection cells were washed three times with PBS+ and treated +/- 250 nM
solubilizing ligand in normal kidney media for 2 hours to allow for ciliary transport.

2.9 Golgi Lock Assay
Golgi lock experiments were performed as described in Matlin and Simons, 1983
[83]. Briefly, RCTE cells were grown on 0.4 µm ﬁlter supports (Falcon-BD
353090, Franklin Lakes, NJ) for 6 days post-confluence. Cells were then
transfected with GFP-OFD1 and either iDimerize-CD16.7-PC1-WT or iDimerizeCD16.7-PC1-359 and cultured in normal kidney media (DMEM/F12, 10% Fetal
Bovine Serum, 2 mM L-glutamine) for 20 hours post-transfection. Cells were then
washed three times with DMEM/F12 Wash Buffer (0.35g DMEM/F12, 60mg
KH2PO4, 10mM Hepes pH 7.4, 0.2% Pen/Strep) and treated with or without 250
nM iDimerize solubilizing ligand in DMEM/F12 Wash Buffer and placed
immediately in a 20ºC water bath for 60-90 minutes. Cells were then washed
three times with PBS, fixed with 3% PFA and processed with co-immunstaining
as described above.
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2.10 GST Pulldown
RCTE cells were grown on 100 mm cell culture dishes for 3-5 days postconfluency to ensure cilia formation. Cells were washed in PBS and lysed on ice
in lysis buffer (200 mM Tris-HCl pH 8.0, 200 mM NaCl, 0.5% NP-40, 1 mM
EDTA, 1 mM PMSF and supplemented with protease inhibitor cocktail
(Calbiochem/EMD Chemicals, Gibbstown, NJ). Lysates were precleared by
centrifugation at 10,000 rpm in an Eppendorf microcentrifuge for 10 minutes and
pretreated with glutathione Sepharose beads (GE Healthcare, Piscataway, NJ);
500 µg of total protein was used for GST pulldown experiments. 500 µg cell
lysate/40 µg glutathione Sepharose beads at 4˚C for 2 hours on a rotator.
Precleared lystate supernatant was transferred to a clean microfuge tube.
GST only, GST-OFD1-CTD and GST-OFD1-NTD were purified using 1 μg DNA
to 50 μl of chemically competent Rosetta cells (defrosted on ice) (E. coli Rosetta
2(DE3) pLysS from Novagen) mixed gently and incubated on ice for 5 minutes,
heat shocked at 42ºC for 30 seconds, and incubated on ice for another 2
minutes. Transformed cells were added to 250 μl of pre-warmed LB media and
incubated at 37ºC, 225 rpm for 1 hour. 100 μl of cells were spread onto LB agar
plates containing the appropriate antibiotic for selection and incubated at 37ºC
overnight. Individual colonies were used to inoculate cultures of LB
supplemented with the appropriate antibiotics. Cultures were grown at 37ºC, 225
rpm until an OD600 of ~0.5 was reached and expression was induced using 0.1
mM IPTG for 3 hours. NOTE: The temperature was then either kept at 37ºC for
GST, GST-OFD1-NTD or adjusted to 22ºC for GST-OFD1-CTD. Cells harvested

53

by centrifugation and resuspended in lysis buffer (PBS containing 1 mM PSMF, 1
mM EDTA, 5 mM DTT, 200 μg/ml lysozyme) and sonicated on ice using 10
cycles of 10 second sonication followed by 20 seconds cooling. Centrifuged at
15000 g for 30 minutes at 4ºC. Supernatant was mixed with 1 ml of glutathione
sepharose 4B beads (GE Healthcare) (pre-washed in 1x PBS three times) and
rotated at 4ºC for 1 hour. Lysate with bead slurry was loaded onto a column and
washed two times with ice cold 1x PBS. Bound protein was eluted in elution
buffer (50 mM Tris-HCl pH 8.0, 25 mM reduced glutathione, 100 mM KCl, 1 mM
DTT, 1 mM PMSF; pH adjusted to 8.0) in several 1 ml fractions. Protein recovery
was determined by SDS-PAGE and Coomasie Blue analysis of aliquots of each
fraction and those containing highest protein levels were pooled and dialysed
against 1x PBS
Purified GST-tagged protein (100 μg) or equimolar GST alone was incubated for
1 hour at 4°C with glutathione Sepharose 4B beads (GE Healthcare) that had
been pre-washed with NETN buffer (200 mM Tris-HCl pH 8.0, 200 mM NaCl,
0.5% NP-40, 1 mM EDTA). Beads were then washed four times with NETN
buffer, resuspended in NETN buffer plus inhibitors (1 mM PMSF and 1mM Sigma
Protease Inhibitor Cocktail) and incubated with 1 mg of pre-cleared RCTE cell
lysate overnight at 4°C. The next day, beads were washed four times with NETN
buffer and resuspended in protein sample buffer for analysis by SDS-PAGE and
western blotting.
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2.11 Statistical Analysis
For biochemical assays, means and standard errors were used to summarize the
data from each experiment. For immunofluorescence experiments a minimum of
30-100 cells/condition were counted. All experiments were repeated at least
three times. For immunoprecipitations and GST pulldown assays, comparisons
across groups were made using one-way analysis of variance (ANOVA) to
determine whether the group means were significantly different. When significant
differences in group means are found, post-hoc multiple comparison tests (e.g.,
Tukey's test) were used to determine which groups are significantly different from
one another. For protein expression analyses and immunofluorescence
quantifications differences were analyzed by unpaired, two-tailed Student’s t test.
GraphPad Prism version 5.0 was used to perform statistical analyses.
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Chapter 3: Results-OFD1 and Flotillins are Integral Components
of a Ciliary Signaling Protein Complex Organized by Polycystins
in Renal Epithelia and Odontoblasts
Stephanie Jerman, Heather H. Ward, Rebecca Lee, Carla A. M. Lopes, Andrew
M. Fry, Mary MacDougall and Angela Wandinger-Ness (2014). OFD1 and
Flotillins are Integral Components of a Ciliary Signaling Microdomain Organized
by Polycystins in Renal Epithelia and Odontoblasts. PLoS One 9(9): e106330.

3.1 Introduction
Oral-facial-digital syndrome type 1 (OFD1; OMIM #311200) is an X-linked
inherited disease characterized by the malformation of the face, oral cavity,
hands and feet caused by heterogeneous mutations in the OFD1 gene also
known as CXORF5. Systemic manifestations of OFD1 mutations include
polycystic kidneys that resemble those caused by mutations in the PKD1 or
PKD2 genes associated with autosomal dominant polycystic kidney disease
(ADPKD) [84,85]. Due to the low rate of kidney transplantation, many patients
with both craniofacial disorders and cystic kidney disease will eventually
succumb to renal failure. Thus, there is an urgent need to clarify how the OFD1
gene product might cross-talk with the pathways regulated by the PKD1 and
PKD2 genes to result in a common disease phenotype.
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Many of the proteins associated with cystic kidney disorders, including PC1 and
PC2 that underlie ADPKD, localize to and function in the primary cilium
[47,71,81,86,87]. The polycystins have pivotal roles in calcium dependent
signaling to multiple pathways and loss of signaling regulation when the proteins
are mutant is thought to cause epithelial cell transdifferentiation and contribute to
renal cyst development [85]. While the associations between defects in primary
cilia, signaling and kidney disease have been recognized for over a decade, it is
only recently that links between cilia, signaling, and tooth defects were revealed.
Deletion of the Ofd1 gene (Ofd1∆4-5/+-) in mice causes missing/supernumerary
teeth, enamel hypoplasia, and polycystic kidney disease analogous to human
oral-facial-digital syndrome type 1 [71]. The observed morphological defects in
molars result from altered differentiation and polarization of odontoblasts when
Ofd1 is mutant [36,71,81]. Localization of OFD1 to the primary cilium of tooth
ectomesenchymal odontoblasts and renal epithelial cells is therefore speculated
to be crucial for proper cellular differentiation of both cell types [71,81].

In related observations in the Tg737 mouse, ectopic teeth (premolars normally
evolutionarily silenced) arise from inactivation of IFT88/polaris in the embryonic
jaw and the consequential increase in sonic hedgehog signaling [88]. The Tg737
mouse was first used to illuminate the central role of IFT88/Polaris in the
development of cystic kidneys [89]. The emerging molecular hierarchy requires
OFD1 to recruit IFT88 as a prerequisite for ciliogenesis and ciliary hedgehog
signaling that also involves the polycystins [77,90,91]. Collectively, these findings
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hint that OFD1 and the polycystins are likely part of the same or overlapping
protein assemblies that control similar ciliary signaling pathways in both
odontoblasts and renal epithelia.

There are some striking similarities in the mechanism by which odontoblasts and
renal epithelial cells respond to external stimuli with the primary cilium of
odontoblasts believed to closely mimic the sensory function of cilia in renal
epithelial cells [92]; thus, the primary cilium likely serves as the critical link
between extracellular mechanical stimuli and initiation of responding intracellular
signaling cascades in odontoblasts and renal epithelial cells. In addition to
altered Hedgehog signaling, aberrant expression and signaling from the tyrosine
kinase EGFR is implicated in both craniofacial disorders and ADPKD [93-95],
and in primary cilia of renal epithelia, EGFR interacts with and regulates PC2 ion
channel activity [87]. Collectively, these data demonstrate the need to
characterize the functional interactions and molecular assemblies of complexes
comprised of signaling receptors, domain-organizing proteins, and ciliary
proteins, which when mutant, cause similar disease phenotypes. I therefore
tested the hypothesis that OFD1 co-assembles into protein complexes
constituted of PC1 and PC2, EGFR, and the flotillin lipid scaffolding proteins in
the primary cilium of renal epithelia and odontoblasts. My findings provide a
molecular explanation for some of the observed commonalities in the
pathogenesis of multi-organ ciliopathies such as OFD1 syndrome and ADPKD.
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3.2 Expression of OFD1, polycystins, flotillins and ErbB receptor family
members in renal epithelia and odontoblasts
I suspected the membrane raft organizing flotillin proteins [96,97] to be key
players in the organization of ciliary signaling complexes. The speculation is
founded on our studies that first identified a cholesterol-rich, flotillin-organized
signaling domain – constituted of polycystins, tyrosine kinases and phosphatases
and cholesterol – at the basolateral membrane of renal epithelia [98,99]. Of
interest is the recent finding that EGFR and downstream signaling partners are
scaffolded in cholesterol-rich signaling domains by the flotillins [100]. Here, I
tested if OFD1 is co-assembled into protein complexes constituted of PC1 and
PC2, EGFR and the flotillin lipid scaffolding proteins in the primary cilium of renal
epithelia and odontoblasts.

The expression of Erythroblastic Leukemia Viral Oncogene (ErbB) receptor
proteins and the flotillins in renal epithelia and odontoblast cells is not well
described. The expression of these and cystic kidney disease proteins were
therefore subjected to comparative immunoblot analyses on polarized renal
cortical tubular epithelial (RCTE) cells and odontoblasts (MO6-G3). PC1 (Figure
12A, B), PC2 (Figure 12C) and OFD1 (Figure 12D), along with the tyrosine
kinase receptors EGFR (Figure 12E) and ErbB2 (Figure 12F) were robustly
expressed in both human renal epithelial cells and mouse odontoblasts in
culture. The signaling domain organizing proteins flotillin-1 (Figure 12H) and
flotillin-2 (Figure 12I) were similarly expressed in both cell types, although
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Figure 12. Key ciliary signaling proteins are expressed in RCTE and MO6G3 cells. Renal cortical tubular epithelial (RCTE) cells and tooth derived
odontoblasts (MO6-G3) cells were lysed and probed with antibodies directed
against indicated proteins. PC1 using NM002 pAb (A, B), PC2 using Santa Cruz
pAb (C), OFD1 using Santa Cruz pAb {Romio, 2004 #54} (D), EGFR using Santa
Cruz pAb (E), ErbB2 using US Biological pAb (F), flotillin-1 using BD
Transduction mAb (H), and flotillin-2 using BD Transduction mAb (I) were found
to be expressed in both cell types. Actin mAb from Millipore (G) was used as a
loading control for PC1, PC2, EGFR, ErbB2, and OFD1; α/β-tubulin pAb from
Cell Signaling (J) was used as a loading control for flotillin-1 and flotillin-2. Actin
or α/β-tubulin was used to normalize results for quantification. Bar graph showing
densitometric quantification of PC1 (a, b), PC2 (c), OFD1 (d), EGFR (e), ErbB2
(f), flotillin-1 (g), flotillin-2 (h). Bar graph represents the mean ± SD of four
independent experiments. (*) p=0.01 to 0.05, (***) p<0.001.
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flotillin-1 exhibited a clear mobility shift in odontoblasts as compared to renal
epithelial cells. The native 460 kDa PC1 is known to be cleaved in cells yielding
several different C-terminal fragments that are important for physiologic functions
[42,47,101]. (N.B. Available antibodies to PC1 recognize different epitopes with
some recognizing the full-length 460 kDa protein while other antibodies
preferentially recognize the 230-250 kDa or 150 kDa PC1 bands).

Renal epithelia and odontoblasts expressed similar levels of both the 460 kDa
and the 150 kDa forms of PC1 (Figure 12a, b), along with EGFR (Figure 12e),
ErbB2 (Figure 12f), flotillin-1 (Figure 12g), and flotillin-2 (Figure 12h). Notably,
protein expression levels of PC2 were 3.4-fold higher (Figure 12c), while OFD1
levels were 3.8 fold lower in odontoblasts as compared to renal epithelia (Figure
12d). These data show that key mechanosensory and signaling proteins such as
the polycystin proteins, OFD1, EGFR, and the flotillins are common to both renal
epithelia and odontoblasts, though there are some variations in the quantitative
levels of the cation channel PC2 and OFD1.

3.3 Colocalization of OFD1, polycystins, EGFR and flotillins to the primary
cilium of odontoblasts and renal epithelial cells
The primary cilium has a distinct protein composition compared to the apical
surface from which it protrudes, and is enriched in signaling proteins that also
function at the basolateral membrane [102,103]. The importance of the primary
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cilium as a signaling command center has been suggested [87,104], yet little is
known about the organization of signaling proteins within primary cilia.

Immunolocalization studies of endogenous and overexpressed proteins were
performed to specifically assess ciliary protein localization patterns in
odontoblasts and renal epithelial cells. Odontoblast cells and fully polarized
RCTE cells are notoriously difficult to transfect via conventional techniques. To
circumvent this problem, I found electroporation (iPorator) on filter surfaces
routinely yielded plasmid transfection efficiencies of 40-50% (see Methods).
Transiently expressed GFP-OFD1 (Figure 13A) and flotillin-2-GFP (Figure 13B)
localized to primary cilia in RCTE cells with some flotillin-2 also on intracellular
structures. Similarly, GFP-OFD1 (Figure 13C) and flotillin-2-GFP (Figure 13D)
localized to primary cilia of odontoblast cells, though there were significant pools
of flotillin-2-GFP elsewhere in the plasma membrane and intracellular structures.
OFD1 is known to be associated with basal bodies and, in some renal cells, to
localize along the ciliary axoneme [81]. Here I found that, particularly in
odontoblasts, GFP-OFD1 staining extended beyond the region expected to
contain just the basal bodies into the ciliary axoneme.
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Figure 13. Transiently transfected GFP-OFD1 and flotillin-2-GFP localize to
primary cilia of RCTE and MO6-G3 cells. Polarized RCTE and MO6-G3 cells
were transiently transfected with either GFP-OFD1 or flotillin-2-GFP constructs.
Upon 16 hours post-transfection, cells were fixed and acetylated α-tubulin (Sigma
Aldrich mAb) was labeled to identify cilia. GFP-OFD1 localized to primary cilia in
RCTE cells (A) and MO6-G3 cells (C). GFP-Flotillin-2 localized to primary cilia of
RCTE (B) and MO6-G3 (D) cells. Images captured using a Zeiss LSM510
confocal microscope (63x objective). Images are representative of at least 3
independent experiments. Arrows denote cilia. Scale bar 10 μm.
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Endogenous protein localizations were evaluated by immunofluorescence
staining using antibodies specifically directed against OFD1, PC1, PC2, EGFR,
and flotillin-1. In RCTE cells OFD1, PC1, PC2, and EGFR localized along the
length of the primary cilium (Figure 14A-D). The ciliary localization of flotillin-2GFP prompted me to look for the flotillin-2 scaffolding partner, flotillin-1. As
expected, endogenous flotillin-1 also localized to primary cilia in RCTE cells
(Figure 14E). Similarly, I observed endogenous OFD1, PC1, PC2, EGFR, and
flotillin-1 protein localization to primary cilia in odontoblast cells (Figure 14F-J).
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Figure 14. Endogenous OFD1, PC1, PC2, EGFR and flotillin-1 localize to
primary cilia of RCTE and MO6-G3 cells. Polarized RCTE and MO6-G3 cells
were fixed and stained using the indicated antibodies. OFD1 from Novus
Biologicals (A, F), PC1 using pAb NM002 (B, G), PC2 using AbCam pAb (C, H),
EGFR using GeneTex pAb (D, I) and flotillin-1 using AbCam pAb (E, J) were
found localized to 100% of primary cilia analyzed for both cell types. Acetylated
α-tubulin (Sigma-Aldrich mAb) labeling identifies cilia. Zeiss LSM510 confocal
microscope images (63x objective). Arrows denote the protein of interest within a
cilium. Representative results from at least 5 independent experiments.
Secondary antibody only controls were negative (not shown). Scale bar 10μm.
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In RCTE cells, I observed co-localization of transiently expressed Flotillin-2-GFP
and PC2 in primary cilia (Figure 15A) as well as Flotillin-2-GFP and EGFR
(Figure 15B), while endogenous EGFR and PC1 co-localized to primary cilia of
RCTE cells (Figure 15C). The ciliary localizations of OFD1, PC1, PC2 and
EGFR are consistent with previous reports showing individual proteins in different
cell types [47,71,81,86,87]. However, I show for the first time the localization of
all 5 proteins, including the membrane organizing flotillins, to primary cilia in a
human kidney cell line. The findings that ciliary protein distributions are similar in
renal epithelia and odontoblasts suggest that these proteins may be similarly
organized in both cell types.
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Figure 15. Two Protein Co-Localization in Primary Cilia of RCTE. Flotillin-2
was transiently transfected into polarized RCTE and cells and then fixed and
stained using the AbCam pAb against PC2 (A) or the GeneTex pAb against
EGFR (B) , Polarized RCTE cells were fixed and stained using the GeneTex pAb
against EGFR and NM002 pAb against PC1 (C). Acetylated α-tubulin (SigmaAldrich mAb) labeling identifies cilia. Zeiss LSM510 confocal microscope images
(63x objective). Arrows denote the protein of interest within a cilium.
Representative results from at least 3 independent experiments. Secondary
antibody only controls were negative (not shown). Scale bar 10 μm.
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To support the microscopy data, polarized RCTE cells were deciliated using
dibucaine-HCl and immunoblot analyses were performed on the ciliary enriched
fraction. The ciliary marker α/β-tubulin was expressed in abundance within the
collected fraction, whereas the nuclear marker lamin B was absent. Given that
the nuclear membrane is often tightly coupled to cilia via a centrosomal
anchoring mechanism, the data support the ciliary enrichment in the absence of
nuclear contamination of the cell fraction. PC1, PC2, and EGFR were all coenriched within the ciliary fraction of RCTE cells providing further evidence for
the presence of signaling proteins within primary cilia (Figure 16).
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Figure 16. Deciliation of RCTE cells. Polarized renal epithelial cells were
treated with 5mM Dibucaine-HCl for 15 minutes causing the cells to shed their
primary cilia. Cilia were collected by fractionation and the ciliary fraction was
probed. PC1 (NM032 pAb), PC2 (Santa Cruz pAb), and EGFR (Santa Cruz pAb)
were expressed in the ciliary fraction of deciliated RCTE cells. The nuclear
marker lamin B (Santa Cruz pAb) was not present in the ciliary fraction.
Representative results from 4 independent experiments. α/β-tubulin was used as
a marker of primary cilia.
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3.4 Polycystins and OFD1 form protein complexes with EGFR and flotillins
in odontoblasts and renal epithelial cells
To determine whether the ciliary proteins of interest are part of a multimeric
complex, I performed immunoprecipitation experiments with specific antibodies
against PC1 and EGFR and scored for co-precipitation of the proteins of interest.
RCTE and odontoblast cells were grown to five days post-confluency to allow for
polarization and ciliogenesis. PC1 was immunoprecipitated from renal epithelial
and odontoblast cell lysate (Figure 17A) and shown to be in complex with PC2
as expected (Figure 17C). The native 460 kDa PC1 contains a region with
potential metalloprotease recognition sequences yielding 230-250 kDa Cterminal fragments [47,105], which were also co-precipitated (Figure 17B). PC1,
along with PC2, becomes tyrosine phosphorylated potentially through the actions
of EGFR [87,99,106]. To test if EGFR is part of the polycystin complex, PC1
immunoprecipitates were probed for EGFR revealing that EGFR was indeed in
complex with PC1 in both cell types (Figure 17D). The non-transmembrane,
ciliary protein OFD1 was also found to be part of the polycystin-EGFR multimeric
complex in renal epithelia and odontoblast cells (Figure 17E), and flotillin-2 is in
complex with PC1 in both cell types (Figure 17F). Quantification of replicate
experiments demonstrated specific co-precipitation of PC2, EGFR, OFD1, and
flotillin-2 with PC1 (Figure 17a-f). In a converse experiment, EGFR was
immunoprecipitated from polarized renal epithelial and odontoblast cell lysates
and probed for PC1, PC2, OFD1, and flotillin-2 (Figure 17G-K).
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Figure 17. PC1, PC2, EGFR, OFD1, and flotillin-2 are part of a multimeric
protein complex in RCTE and MO6-G3 cells. RCTE and MO6-G3 cells were
grown 5 days post-confluency to allow for polarization and ciliogenesis. PC1 was
immunoprecipitated using NM002 pAb and precipitated proteins were separated
by SDS-PAGE and probed for PC1 using NM005 pAb (A, B), PC2 using AbCam
pAb (C), EGFR using GeneTex pAb (D), OFD1 using Novus Biologicals pAb (E)
and flotillin-2 using Cell Signaling Rabbit mAb (F). Bar graph showing a
densitometric quantification of PC1 co-immunoprecipitation for PC1 (a,b), PC2
(c), EGFR (d), OFD1 (e), and flotillin-2 (f). Normal rabbit IgG was used as a
negative control. In a reciprocal experiment EGFR was immunoprecipitated using
Santa Cruz pAb from RCTE and MO6-G3 cell lysates. Immunoprecipitated
proteins were separated by SDS-PAGE and probed for EGFR using GeneTex
pAb (G), PC1 using NM002 pAb (H), PC2 using Santa Cruz pAb (I), OFD1 using
Novus Biologicals pAb (J) and flotillin-2 using Cell Signaling Rabbit mAb (K). Bar
graph showing a densitometric quantification of EGFR co-immunoprecipitation
probed for EGFR (g), PC1 (h), PC2 (i), OFD1 (j), and flotillin-2 (k). Normal rabbit
IgG was used as a negative control. Lysate lane inputs were 5% of
immunoprecipitations. 25 µg of total protein was loaded into each well. Arrows
indicate the quantified band of interest in each immunoblot panel. Bar represents
the mean ± SD of at least three independent experiments. (*) p=0.01 to 0.05, (**)
p=0.001 to 0.01, (***) p<0.001.
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As seen in the PC1 immunoprecipitates, all of the proteins were co-enriched with
EGFR (Figure 17g-k), with a cleaved fragment of PC1 preferentially coprecipitated with EGFR. Multiple OFD1 bands are present in RCTE and MO6-G3
cell lysates and a subset of these OFD1 bands are co-precipitated with EGFR.
Interestingly, the flotillin-2 bands were notably upshifted in both the PC1 and
EGFR immunoprecipitates suggesting posttranslational modification within these
complexes. These data indicate that key ciliary signaling proteins – PC1, PC2,
EGFR and OFD1 – may well reside in a complex with membrane organizing
flotillin proteins in renal and dental cell types.

3.5 Polycystin-1 and EGFR form a complex within primary cilia
I utilized an antibody-based proximity ligation assay to specifically evaluate if the
protein complexes I identified by co-immunoprecipitation were resident in cilia
[107]. Using antibodies directed against the extracellular domains of PC1 and
EGFR, these two proteins were found to interact specifically within the primary
cilium of odontoblasts (Figure 18A) and fully polarized renal epithelial cells
(Figure 18B). In both cell types the fluorescent signal was notably concentrated
in puncta, suggestive of specialized domains wherein the proteins are enriched.
In the relatively short cilia of odontoblasts, a less concentrated signal was also
seen along the length of the shaft. Puncta associated with the cell body were
largely intracellular with a small fraction at or near the basolateral membrane
(Figure 18A-B and data not shown). Experiments performed without primary
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Figure 18. PC1 and EGFR interact in the primary cilium of MO6-G3 and
RCTE cells. Polarized MO6-G3 (A) and RCTE (B) cells were grown on
coverslips 5 days post-confluency. Cells were incubated with antibodies against
PC1 (Santa Cruz mAb) and EGFR (GeneTex pAb), followed by Duolink PLA
Probes to identify points of PC1-EGFR interaction. Cilia identified by acetylated
α-tubulin (Sigma-Aldrich mAb). Identical experiments performed without PC1
antibody are negative for fluorescent signal (C). Top panel shows XY plane,
bottom panel shows XZ plane. Images from confocal microscope (63x objective).
Scale bar is 5 μm. Quantification of puncta in 3 representative images (11-29
cells/field) from 2 independent experiments (D). Quantification of cilia containing
PLA puncta (E). Puncta in cilia were counted based on colocalization with
acetylated α-tubulin. Statistical evaluation based on two-tailed t-test. p=0.0194.
Movie can be found at the following web address:
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0106330
#s5.
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antibody against PC1 yielded no fluorescent signal verifying the specificity of the
PC1-EGFR reaction (Figure 18C).

Quantification of these proximity-induced fluorescent puncta showed an
enrichment in the cilia (62%) as compared to the cell body (38%) of fully
polarized RCTE cells (Figure 18D). The pattern in odontoblasts was reversed
with a greater fraction of puncta in the cell body (90%), yet retaining a
quantifiable fraction in cilia (10%) (Figure 18D). Both cell types had similar
numbers of ciliated cells (RCTE 82%; MO6-G3 93%), although the average cilia
length was different (RCTE 6.10 µm; MO6-G3 0.49 µm). Both RCTE and MO6G3 had a similar percentage of primary cilia containing puncta: RCTE 53.4%;
MO6-G3 62.6% (Figure 18E). Taken in conjunction with previous data showing
PC1 and PC2 interact in primary cilia [77] and PC2 forms a ciliary signaling
complex with EGFR [87], these data indicate that PC1 and PC2 likely form a
three way complex with EGFR in cilia.

3.6 Mutant expression of PC1 results in decreased ciliary localizations of
PC2, OFD1, EGFR and flotillin-1
Given the shared disease pathologies caused by mutant OFD1 and PKD genes, I
tested if the expression of a mutant component of our defined ciliary signaling
complex would in turn affect the formation and/or stability of these specialized
complexes. In cells from patients with ADPKD, expression of mutant PC1 often
results in its absence from primary cilia [108]. Immunolocalization studies were
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therefore performed on cells from human ADPKD patients with expression of
mutant PC1 (Q4004X) [76]. In these cells, there was reduced expression not only
of PC1, but also of the associated PC2, EGFR, and flotillin-1 proteins along the
shaft of primary cilia (Figure 19A-H). Quantification of multiple data sets verified
statistically significant reductions (p<0.0001 for PC1, PC2, and flotillin-2;
p=0.0105 for EGFR) in all components of the complex (Figure 19I-L). A small
residual pool of EGFR was sometimes detectable at the ciliary base. OFD1
localization to primary cilia was also significantly decreased in PKD cells as
compared to RCTE cells (p<0.0001; data not shown).
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Figure 19. Key ciliary signaling proteins are significantly reduced in
primary cilia of PKD cells. Human RCTE and PKD Q4004X cells (with
expression of mutant PC1) were grown on coverslips 5 days post-confluency to
permit ciliogenesis. Cells were fixed and stained using antibodies directed
against indicated proteins: PC1 (NM002 pAb); PC2 (AbCam pAb); EGFR
(GeneTex pAb); and flotillin-1 (AbCam pAb). PC1 (A), PC2 (C), EGFR (E) and
flotillin-1(G) are present in primary cilia of RCTE cells. PC1 (B), PC2 (D), EGFR
(F) and flotillin-1 (H) were lacking in primary cilia of PKD Q4004X cells.
Acetylated α-tubulin (Sigma-Aldrich mAb) staining identifies cilia. Arrows denote
a small residual pool of EGFR detectable at the ciliary base of PKD cells. Zeiss
LSM510 confocal microscope images (63x objective). Representative results
from at least 5 independent experiments. Comparative images are from a single
experiment and taken under identical settings. Arrows denote cilia. Scale bar 10
μm. Quantification shows individual ciliary protein intensities normalized to the
respective ciliary volume (I-L). Each protein was quantified in 30-100 cilia for
each cell type. z-stack images were imported into SlideBook and a volume mask
for each cilium was created based on acetylated α-tubulin staining. Staining
intensities for each protein were quantified within the respective ciliary volume
mask. Statistical evaluation based on two-tailed t-test. (*) p=0.0105, (***)
p<0.0001.
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As further confirmation, I also analyzed OFD1 localization in primary human
normal kidney and PKD (46M06) cells. Whilst OFD1 localized to primary cilia of
primary normal proximal tubular epithelial cells (RPTEC) cells (Figure 20A), it
was significantly decreased (p<0.0036) in primary cilia of 46M06 cells (Figure
20B, C). To substantiate these studies, zoomed in images of 46M06 primary cilia
were taken and confirmed the absence of OFD1 in cystic renal epithelia primary
cilia (Figure 21).
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Figure 20. OFD1 ciliary localization is altered in human primary cell lines.
Human primary renal proximal tubule epithelial cells (RPTEC) and PKD (44M06)
cells were grown on glass coverslips 5 days post confluency to allow for
ciliogenesis, fixed and stained using an antibody directed against OFD1 (Santa
Cruz pAb). OFD1 localizes to primary cilia in RPTEC cells (A) but is diminished in
primary cilia PKD 46M06 cells (B). Acetylated α-tubulin (Sigma-Aldrich mAb)
staining identifies cilia. Zeiss LSM510 confocal microscope images (63x
objective). Representative results from 3 independent experiments. Comparative
images are from a single experiment and taken under identical settings. Arrows
denote cilia. Scale bar 10 μm. Quantification shows OFD1 staining intensities
normalized to ciliary volumes, performed as detailed in methods and Figure 6
(C). z-stack images were imported into SlideBook and a mask for the cilia was
created based on acetylated α-tubulin staining. Statistical evaluation based on
two-tailed t-test. (**) p=0.0036.
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Figure 21. OFD1 is reduced in primary cilia of PKD 46M06 cells. Polarized
46M06 PKD cells were fixed and stained using an antibody directed against
OFD1 (Novus Biologicals pAb). Acetylated α-tubulin (Sigma-Aldrich mAb)
labeling identifies cilia. 63x objective with no zoom (A), 63x zoomed in image of
panel A cilia marked with arrows (B), 63x zoomed in images of separate fields of
view (C-D). Zeiss LSM510 confocal microscope images. Representative results
from at least 3 independent experiments. Secondary antibody only controls were
negative (not shown). Scale bar 10 μm.
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Biochemical deciliation experiments were used to independently verify that all
components of the identified ciliary complex were decreased in an
interdependent manner when polycystin-1 is mutant. Polarized RCTE and PKD
(Q4004X) cells were deciliated using Dibucaine-HCL and isolated ciliary fractions
analyzed by immunoblot. Quantification of OFD1, EGFR, and flotillin-1 protein
levels relative to α/β-tubulin levels confirmed that all components were reduced
in the ciliary fraction of the PKD cells as compared to RCTE cells (Figure 22).
These data further substantiate the conclusion that the OFD1-EGFR-flotillin
complex is lost from cilia in cells with mutant PC1. While siRNA-mediated
ablation of OFD1 and PC1 were attempted in renal epithelia and odontoblasts,
these studies were complicated by the fact that OFD1 is necessary for
ciliogenesis and therefore siRNA knockdown must be performed after cells are
fully polarized and have cilia. Under these conditions, a population of OFD1
remained resident in primary cilia even after 48 h of siRNA-mediated knockdown
precluding accurate interpretation. The composite data demonstrate that the
proteins are organized into a functional complex that is disrupted when
polycystin-1 is mutant or absent.
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Figure 22. Expression of PC1, OFD1, EGFR, and Flotillin-1 is decreased in
ciliary fractions of PKD cells compared to RCTE cells. RCTE cells and PKD
Q4004X cells were grown 6 days post-confluency to allow for cell polarization
and ciliogenesis and treated with 1.5 mM Dibucaine-HCl for 5 minutes to reduce
cell loss and induce shedding of primary cilia. Cilia were collected by
fractionation and the ciliary fraction was probed. PC1 (MN032 pAb), OFD1
(Novus Biologicals pAb), EGFR (GeneTex pAb), and flotillin-1 (BD Transduction
mAb) were expressed in the ciliary fraction of deciliated RCTE cells but not PKD
cells. α/β-tubulin (Cell Signaling pAb) was used as a marker of primary cilia. The
nuclear marker lamin B (Santa Cruz pAb) was not present in the ciliary fraction
(A). Quantification of 3 independent samples (B). Mean values were found to be
statistically different (p<0.0001) using 1-way ANOVA.
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Chapter 4: Results-OFD1 Interacts with Polycystin-1 for OFD1
Localization to Primary Ciliary

4.1 Introduction
Oral-facial-digital syndrome type1 (OFD1; OMIM #311200) is an X-linked
inherited disease caused by expression of mutant OFD1 protein resulting in
cognitive defects and malformations of the oral cavity, hands, and feet along with
PKD. Over the past decade, advancements in renal ultrasound technology have
shown that PKD is more intimately associated with OFD1 than was previously
recognized and, in fact, renal symptoms often dominate the clinical course of the
disease. Due to the low rate of kidney transplants, many OFD1 patients will die
from ESRD due to PKD. Recent studies have shown that PKD in OFD1 patients,
caused by mutation in the OFD1 gene, very closely mimics the disease variability
and kidney disease pathogenesis seen in patients with Autosomal Dominant
Polycystic Kidney Disease (ADPKD), caused by mutations in the PKD1 or PKD2
genes, which encode PC1 or PC2 proteins, respectively. ADPKD is a common
inherited disorder that affects between 1:500 to 1:1000 individuals worldwide and
leads to renal failure in adulthood. Because the renal pathologies observed in
OFD1 and ADPKD are virtually indistinguishable, and many of the oral, facial,
and digital abnormalities are surgically corrected in childhood, it is believed that
many OFD1 patient classifications may be overlooked. OFD1 is embryonic lethal
in males, so it is now being recommended that an OFD1 diagnosis be suspected
in families where ADPKD affects only the females.
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OFD1 and ADPKD are included in an expanding list of inherited human diseases
that are caused by dysfunction of primary cilia associated proteins, termed
ciliopathies. This once largely ignored organelle is now being recognized for its
importance in a number of cellular processes including embryonic development,
organ homeostasis, and signaling events to relay messages from the
extracellular environment into the cell [52,60,109,110]. In addition to OFD1,
PKD1, and PKD2, there is a growing list of genes that have been identified to
cause ciliopathies, yet there are many commonalties emerging in these
genetically diverse disorders. Primary cilia are now widely considered the central
cellular component involved in the pathogenesis of cystic kidney disease and
ciliopathies often share similarities in extrarenal pathologies such as
cardiovascular and skeletal abnormalities [111]. Growing evidence supports that
commonalities observed in many ciliopathies are due to the intersection of
signaling pathways harbored in the primary cilium. In fact, over the past decade,
the primary cilium has emerged as the signaling hub of the cell due to the large
number of signaling proteins that have been found to localize to this specialized
cellular organelle. For example, in polarized renal epithelia, PC1 and PC2
interact to form a receptor-channel complex in primary cilia. There is evidence
that PC1 acts as a mechanosensor in primary cilia to sense extracellular fluid
flow and subsequently activate PC2 Ca2+ channel activity in the cilia.
Furthermore, PC2 is associated with the EGFR in the primary cilium, and EGFR
regulates PC2 calcium channel activity from this location [52]. Though the
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amount of calcium translocated in the cilium is too small to change overall
intracellular calcium levels, there is evidence that it is a pivotal signaling event
with mechanistic details under active investigation [112-114]. Not surprisingly,
aberrant activation and mislocaliztion of EGFR has emerged as a complicating
factor in a number of known ciliopathies, including ADPKD and ARPKD, and
many craniofacial disorders [54,60,93,115,116]. The connection between
mislocalization of ciliary signaling proteins and human disease has revealed the
need to better understand how proteins are delivered to this cellular location.

Our group, along with others, has shown the importance of a conserved peptide
sequence (VxPx) that is important for the proper delivery of transmembrane
proteins, such as the polycystins, to primary cilia [43,117,118]. However, the
mechanism by which OFD1, a soluble protein, arrives at primary cilia remains
enigmatic. OFD1 normally localizes to centrosomes during cell division where it
functions to control mother/daughter centriole length and later, when cells are
fully polarized, OFD1 localizes to the base of the primary cilia as well as the
ciliary shaft [60,63,64]. In normal renal epithelia, OFD1 is a component of a
conserved ciliary microdomain consisting of the polycystins and EGFR [60].
Human ADPKD cystic epithelial cells expressing mutant PC1 protein exhibit not
only a failure of PC1 to localize to cilia, but also a decreased localization of PC2,
EGFR, and OFD1 to primary cilia [60,119]. The finding that loss of ciliary PC1
leads to decreased OFD1 within the ciliary shaft suggests that PC1 might also
serve to promote delivery and/or stable localization of OFD1 to primary cilia [60];
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motivating a detailed mechanistic analysis of OFD1 dependence on PC1 for
trafficking to cilia.

OFD1 contains five to six predicted CC domains [34,86]. Increasing evidence
supports a role for CC domains in protein-protein interactions and protein
trafficking to various cellular locations, and it is has been shown that these
domains have roles in the localization of OFD1 to centrosomes [64]. PC1 and
PC2 also contain CC domains that mediate their intracellular interaction. Studies
have shown that PC2 interaction with PC1 via the CC domains is required for
PC2 to correctly localize to primary cilia [120]. Although PC2 can arrive at the
ciliary membrane independently of PC1 [117], the stable expression of PC2 in
primary cilia is dependent on PC1 [60].

Based on previous findings, there are four plausible routes for OFD1 ciliary
delivery (Figure 23). The first possibility is that OFD1 is packaged in vesicles
with PC1 beginning at the ER and/or at the Golgi and the two proteins are
delivered together to the cilia utilizing the VxPx ciliary targeting motif found in
PC1 (Figure 23A). Second, OFD1 could require a direct interaction with PC1 via
the CC domains in both proteins to “hitchhike” with PC1 for delivery to primary
cilia (Figure 23B). Third, OFD1 may arrive at the base of the primary cilium
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Figure 23. Proposed models for OFD1 trafficking to primary cilium. We
propose four possible routes for OFD1 ciliary delivery. (A) OFD1 is packaged in
vesicles with PC1 at the Golgi and the two proteins are delivered together to the
cilia utilizing the VxPx motif found in PC1. (B) OFD1 interacts with PC1 via CC
domains for ciliary delivery. (C) OFD1 arrives at the base of the primary cilium
independently of PC1 and is involved in the docking of vesicles for integration
into the primary cilium. (D) OFD1 arrives at the primary cilium independently and
is subsequently organized into a ciliary microdomain containing PC1. Utilization
of the iDimerize (pink cassettes = DmrD domains) CD16.7-PC1 C-terminal tail
constructs will allow for analysis of spatial and temporal interaction of OFD1 with
PC1 at various subcellular locations.
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independently of PC1 and be involved in the docking of vesicles for integration
into the primary cilium (Figure 23C). Lastly, OFD1 might arrive at the primary
cilium independently and subsequently become organized into a ciliary
microdomain containing PC1 (Figure 23D). Characterization of the molecular
basis for the interaction between membrane proteins (such as polycystins) and
soluble proteins (such as OFD1) is important to distinguish the role of PC1 in
ciliary protein transport and/or stabilization within the ciliary shaft.

4.2 iDimerize-CD16.7-PC1-WT, but not iDimerize-CD16.7-PC1-359 mutant
lacking the VxPx targeting motif, localizes to primary cilia of renal epithelial
cells
Previous studies showed that a conserved amino acid motif (VxPx) is vital for
recognition of ciliary membrane proteins, such as PC1, PC2, and rhodopsin (a
photoreceptor expressed in retinal epithelia) by a GTPase driven trafficking
machinery and ciliary transport fidelity [43,117,118]. When the VxPx motif is
mutant or absent from PC1 or PC2, these proteins are excluded from the primary
cilia. The VxPx sorting motif is recognized by the small GTPase Arf4, which
functions as an important regulator of protein trafficking from the Golgi apparatus
to the base of the cilium [43,118]. In a previous study from our lab, the Cterminus of PC1 containing the VxPx motif was demonstrated to be required for
PC1 targeting to primary cilia of renal epithelia by utilizing a series of PC1 fusion
proteins [43]. The chimeric protein constructs consisted of an N-terminal
ectoplasmic domain derived from human CD16 (which facilitates protein retrieval
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and analyses as well as selective immunolocalization) and the transmembrane
domain of human CD7 followed by the membrane distal C-terminus of human
PC1. Successive deletion of more and more of the PC1 tail, starting from the
extreme C-terminal end of PC1 tested the importance of various sequences in
the ciliary localization of PC1 (Figure 24). The CD16.7-PC1-WT tail fusion
protein localized to primary cilia of RCTE cells, while a CD16.7-PC1-359
truncation mutant construct lacking the last 20 amino acids, including the ciliary
targeting VxPx motif, failed to localize to primary cilia [47].

91

Figure 24. Cartoon representation of CD16.7-PC1 fusion proteins. The
chimeric protein constructs consisted of an N-terminal ectoplasmic domain
derived from human CD16 (which facilitates protein retrieval and analyses as
well as selective immunolocalization) and the transmembrane domain of human
CD7 followed by the membrane distal wild-type 112 amino acids of the PC1
cytoplasmic C-terminal tail (A). The last 20 amino acids of the CD16.7-PC1-WT
tail were deleted to produce the CD16.7-PC1-359 truncation mutant lacking the
ciliary targeting VxPx motif (B).
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In the present study, I took advantage of these previously characterized
constructs to determine if PC1 was required for OFD1 localization to primary
cilia. In order to accomplish this, I utilized a reversible dimerization system
(iDimerize) to test several possibilities for the spatio-temporal assembly of OFD1
with the polycystins (described in Figure 23). The ‘iDimerizeTM’ cassettes
containing an ER targeting signal (Clontech, custom synthesis detailed in
Materials and Methods) cause protein oligomerization and trapping in the ER that
can be released with the addition of a ligand (called solubilizer and based on the
reversible, ligand-dependent relief of the oligomerization of the FKB508 protein
[121,122]). The addition of ligand allows disaggregation and synchronous plasma
membrane transport, which can be monitored by immunofluorescence staining
(Figure 25).
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Figure 25. Schematic showing the iDimerize reversible dimerization
system. The ‘iDimerizeTM’ cassettes contain an ER targeting signal (Clontech)
and cause protein oligomerization and trapping in the ER (A, a) that can be
released with the addition of a solubilizing ligand (B). The addition of ligand
allows disaggregation and synchronous release of iDimerize-CD16.7-PC1 fusion
protein from ER. Cells can then be placed at 20˚C to accumulate protein in Golgi
(C) or keep cells at 37˚C to allow for plasma membrane transport (D), which can
be monitored by immunofluorescence staining.
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The iDimerizeTM’ cassettes were cloned in frame in front of the N-terminus of the
CD16.7-PC1-WT and CD16.7-PC1-359 chimeras. The iDimerize-CD16.7-PC1WT and iDimerize-CD16.7-PC1-359 fusion constructs (Figure 26A) were
transfected into polarized RCTE cells. Before addition of solubilizing ligand, both
the iDimerize-CD16.7-PC1-WT and iDimerize-CD16.7-PC1-359 constructs
exhibit perinuclear staining indicative of being trapped in the ER (Figure 26B
and data not shown). Treatment of cells with 250 nM solubilizer causes the
disruption of iDimerize protein oligimerization in the ER and synchronous release
of iDimerize fusion proteins to the Golgi where the iDimerize cassettes are
cleaved off during protein processing, allowing for proper packaging of CD16.7PC1 constructs by the subsequent cellular sorting pathways. The iDimerizeCD16.7-PC1-WT construct successfully localized to primary cilia (Figure 26C),
while the iDimerize-CD16.7-PC1-359 construct failed to localize to primary cilia of
RCTE cells (Figure 26D). The significant reduction in ciliary localization of
iDimerize-CD16.7-PC1-359 mutant protein lacking the ciliary targeting VxPx motif
compared to the iDimerize-CD16.7-PC1-WT construct (Figure 26E) corroborates
our previous finding that the VxPx motif is essential for trafficking of PC1 to
primary cilia of renal epithelial cells. These studies verified the fidelity of the
iDimerize-CD16.7-PC1-WT and iDimerize-CD16.7-PC1-359 constructs for the
study of OFD1 and PC1 protein-protein interactions en route to primary cilia;
starting with PC1 synthesis in the ER and subsequent transport through the
secretory pathway from the Golgi apparatus to primary cilia.
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Figure 26. iDimerize-CD16.7-PC1-WT, but not iDimerize-CD16.7-PC1-359,
localizes to primary cilium. Schematic of iDimerize PC1 fusion proteins and
GFP OFD1. iDimerize PC1 fusion proteins consist of an ‘iDimerizeTM’ cassette
containing an ER targeting signal (Clontech) fused to the NH2-terminal
ectoplasmic domain of human CD16 followed by the transmembrane domain of
human CD7 and the membrane distal C-terminus of human PC1 C-terminal tail
with or without the VxPx ciliary targeting motif. GFP-OFD1 consists of eGFP
fused to the N-terminus of full-length OFD1 (A). RCTE cells were grown on 0.4
μm filter supports 4 days post confluency to allow for polarization and transfected
with the iDimerize-CD16.7-PC1-WT or iDimerize-CD16.7-PC1-359 truncation
mutant construct. Post-transfection (16 hours) cells were incubated +/- solubilizer
and stained with antibody against CD16. Perinuclear staining of iDimerizeCD16.7-PC1-WT construct locked in endoplasmic reticulum due to absence of
solubilizer (B).Following 2 hour treatment with solubilizer, iDimerize-CD16.7PC1-WT localizes to primary cilia (C) while iDimerize-CD16.7-PC1-359 fails to
localize to cilia (D). α/β-tubulin labeling identifies cilia. Arrows denote the protein
of interest within a cilium. Zeiss META confocal microscope images (63x
objective). Secondary antibody only controls were negative (not shown). Scale
bar 10 μm. Quantification shows ciliary protein intensities normalized to the
respective ciliary volume (E). Each protein was quantified in 30-100 cilia for each
cell type. z-stack images were imported into SlideBook and a volume mask for
each cilium was created based on α/β-tubulin staining. Staining intensities for
each protein were quantified within the respective ciliary volume mask. Mean
values were found to be statistically different (p<0.0001) using 1-way ANOVA.
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4.3 Expression of iDimerize-CD16.7-PC1-359 mutant impairs the ability of
GFP-OFD1 to localize to primary cilia
To address the possibility that OFD1 ciliary localization is dependent on the VxPx
ciliary targeting motif in PC1, I tested if OFD1 expression with a PC1 VxPx
mutant would affect the ciliary localization of OFD1. I have previously shown
overexpressed GFP-OFD1 localization to primary cilia of RCTE cells [60]. Here, I
co-transfected RCTE cells with GFP-OFD1 and either the iDimerize-CD16.7PC1-WT or iDimerize-CD16.7-PC1-359 VxPx mutant. This allowed analysis of
how newly synthesized OFD1 protein localization to primary cilia is affected by
PC1 ciliary localization. Before addition of solubilizing ligand, the iDimerizeCD16.7-PC1-WT construct exhibits a nuclear envelope and contiguous
perinuclear staining indicative of the iDimerize-CD16.7-PC1 protein aggregation
in the ER (Figure 27A). As expected, there was no ciliary localization of the
iDimerize-CD16.7-PC1 construct before addition of solubilzer due to protein
accumulation in the ER. GFP-OFD1 successfully localized to primary cilia of cells
that did not co-express iDimerize-CD16.7-PC1 constructs (data not shown),
corroborating our previous studies showing ciliary localization of GFP-OFD1 in
cells expressing only endogenous PC1 [60]. Interestingly, GFP-OFD1 failed to
localize to primary cilia in cells where iDimerize-PC1 was trapped in the ER,
suggesting that OFD1 requires PC1 for ciliary delivery. Upon addition of
solubilizing ligand, iDimerize-CD16.7-PC1-WT localizes to primary cilia, along
with GFP-OFD1 (Figure 27B). However, iDimerize-CD16.7-PC1-359 fails to
localize to cilia upon addition of solubilizer. In the cells expressing iDimerize-
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Figure 27. GFP-OFD1 fails to localize to cilia of cells expressing the
iDimerize-CD16.7-PC1-359 mutant. Polarized RCTE grown on 0.4 µm filter
supports were co-transfected with GFP-OFD1 and either the iDimerize-CD16.7PC1-WT or iDimerize-CD16.7-PC1-359 truncation mutant construct. Posttransfection (16 hours) cells were incubated +/- solubilizer and stained with
antibody against CD16. GFP-OFD1 exhibits cytoplasmic localization but fails to
localize to primary cilia in cells without solubilizer when iDimerize-PC1-CD16.7PC1 construct is locked in ER (A). Following 3 hour treatment with solubilizer,
iDimerize-CD16.7-PC1-WT along with GFP-OFD1 localize to primary cilia (B)
while GFP-OFD1 is absent from cilia in cells expressing iDimerize-CD16.7-PC1359 (also absent from cilia) (C). α/β-tubulin labeling identifies cilia. Arrows denote
the protein of interest within a cilium. Secondary antibody only controls were
negative (not shown). Zeiss LSM META confocal microscope images (63x
objective). Scale bar 10 μm.Quantification shows ciliary protein intensities
normalized to the respective ciliary volume as detailed in Figure 1 (D). Mean
values were found to be statistically different (p<0.0001) using 1-way ANOVA.
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CD16.7-PC1-359, there is also a significant decrease of GFP-OFD1 localized to
primary cilia (Figure 27C, D). The reduction in ciliary GFP-OFD1 is similar
between the cells expressing the iDimerize-CD16.7-PC1-359 mutant and those
without solubilizer where the iDimerize-CD16.7-PC1 construct is trapped in the
ER (Figure 27D). These data suggest that OFD1 requires PC1 for correct ciliary
localization and/or stabilization of OFD1 in the ciliary shaft.

To further confirm the findings, the proteins were accumulated in the Golgi using
a 20°C temperature block as described previously [83]. Briefly, I co-transfected
RCTE cells with GFP-OFD1 and either the iDimerize-CD16.7-PC1-WT or
iDimerize-CD16.7-PC1-359 mutant and allowed the iDimerize-CD16.7-PC1
constructs to accumulate in the ER for 16 hours. Before addition of solubilizer,
the iDimerize-CD16.7-PC1-WT protein was concentrated in the nuclear envelope
and contiguous perinuclear ER affirming efficacy of transfection and experimental
protocol (Figure 28A). Upon addition of solubilizer, cells were transferred to a
reduced temperature (20°C) water bath to cause the iDimerize constructs to
synchronously exit from the ER and accumulate in the Golgi. After 1 hour at
20°C, both the iDimerize-CD16.7-PC1-WT (Figure 28B) and iDimerize-CD16.7PC1-359 (Figure 28C) largely disappeared from the ER/nuclear envelope and
were instead found in punctate structures in a crescent around the nucleus
suggestive of transport to the Golgi. The iDimerize-CD16.7-PC1-359 mutant
exhibits greater residual PC1 ER staining suggesting that the iDimerize-CD16.7PC1-359 mutant while able to exit the ER to the Golgi, may do so more slowly
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Figure 28. Golgi accumulation of iDimerize-CD16.7-PC1 constructs.
Polarized RCTE cells grown on 0.4 µm filter supports were co-transfected with
GFP-OFD1 and either the iDimerize-CD16.7-PC1-WT or iDimerize-CD16.7-PC1359 truncation mutant construct. Post-transfection (16 hours) cells were
incubated +/- solubilizer and placed at 20 degrees Celsius for 60-90 minutes to
lock proteins in Golgi. Cells were then fixed and stained with antibody against
CD16. Before addition of solubilizer, iDimerize-CD16.7-PC1 construct are locked
in ER while GFP-OFD1 is localized to cytoplasm (A). After treatment with
solubilizer, iDimerize-CD16.7-PC1-WT (B) and CD16.7-PC1-359 (C) constructs
exhibit punctate staining in area surrounding ER indicative of accumulation in
Golgi. GFP-OFD1 co-localizes with iDimerize-CD16.7-PC1 intracellularly (D).
Arrows denote areas of GFP-OFD1 and iDImerize-CD16.7-PC1 co-localization.
Zeiss LSM META confocal microscope images (63x objective). Secondary
antibody only controls were negative (not shown). Scale bar 10 μm.
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than the iDimerize-CD16.7-PC1-WT protein. GFP-OFD1 was largely cytoplasmic;
however, there were discrete puncta showing GFP-OFD1 co-localized with
iDimerize-CD16.7-PC1 in the area surrounding the perinuclear region upon
release from ER (Figure 28D). In cells where PC1 is locked in the ER or mutant,
GFP-OFD1 cannot localize to primary cilia but does co-localize with PC1
intracellularly. This suggests that the failure of GFP-OFD1 to localize to cilia may
be due to OFD1 being trapped with the iDimerize-CD16.7-PC1-359 VxPx mutant
in the ER or Golgi. Taken together, these data suggest that stable expression of
OFD1 in primary cilia is dependent on PC1 ciliary localization.

4.4 CD16.7-PC1-L152P coiled coil mutant causes a reduction in OFD1
localization to primary cilia
The interaction of the polycystin proteins, PC1 and PC2, via CC domains is
required for PC2 stabilization in the ciliary membrane [120]. Therefore, it was of
interest to test the possibility that OFD1 ciliary localization is dependent on
interaction with PC1 via the CC domains present in both proteins. We have
previously shown that the PC1 tripartite fusion proteins CD16.7-PC1-WT and
PC1 CC domain mutant CD16.7-PC1-L152P both correctly localize to primary
cilia of kidney epithelial cells [43,119]. To test if the expression of the CD16.7PC1-L152P CC mutant might affect OFD1 ciliary localization, we co-transfected
RCTE cells with GFP-OFD1 and either CD16.7-PC1-WT or CD16.7-PC1-L152P.
In the positive control sample, GFP-OFD1 localized to primary cilia in cells
expressing CD16.7-PC1-WT protein (Figure 29A). However, in cells
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overexpressing the CD16.7-PC1-L152P CC mutant GFP-OFD1 failed to localize
to primary cilia (Figure 29B). These data indicate that the CC domain in PC1 is
crucial for OFD1 interaction and for stable OFD1 ciliary localization.
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Figure 29. GFP-OFD1 fails to localize to cilia in cells expressing the CD16.7PC1-L152P coiled coil mutant. Polarized RCTE cells grown on 0.4 µm filter
supports were co-transfected with GFP-OFD1 and either the CD16.7-PC1-WT or
CD16.7-PC1-L152P coiled coil mutant construct. Post-transfection (16 hours)
cells were then fixed and stained with antibody against CD16. CD16.7-PC1-WT
and GFP-OFD1 localize to primary cilia (A). While the CD16.7-PC1-L152P
mutant is able to localize to cilia, GFP-OFD1 fails to co-localize to cilia in cells
expressing the CD16.7-PC1-L152P coiled coil mutant (B). α/β-tubulin labeling
identifies cilia. Arrows denote the protein of interest within a cilium. Zeiss LSM
META confocal microscope images (63x objective). Secondary antibody only
controls were negative (not shown). Scale bar 10 μm.

106

4.5 OFD1 interacts with PC1 via coiled coil domains
I previously showed that OFD1 interacts with PC1, but the domains important for
this interaction remained unknown [60]. For reciprocal confirmation of an
interaction between PC1 and OFD1 dependent on the CC domains, in vitro
binding experiments were conducted using a CC deletion mutant of OFD1. OFD1
is comprised of a short N-terminus containing a LisH motif and a much longer Cterminus with five to six predicted CC domains (Figure 30A).

107

Figure 30. PC1 interacts with coiled coil domains of OFD1. Cartoon depicted
full-length OFD1 with a N-terminal LisH motif and a longer C-terminus comprised
of six predicted coiled coil domains. Constructs used for this study consisted of a
GST tag fused to either the C-terminus of OFD1 containing the coiled coil
domains or GST fused to the N-terminus of OFD1 without coiled coil domains
(A). Glutathione resin-bound GST (~25kDa), GST-OFD1-CTD (~129 kDa) and
GST-OFD1-NTD (~44kDa) was incubated with cell lysate of polarized RCTE
cells. After washing, the pulled-down complexes were subjected to SDS-PAGE
and analyzed by Western blotting using anti-GST and anti-PC1 antibodies. While
all GST constructs (and GST alone) were present in GST pulldowns at their
correct sizes (B) only the GST-OFD1-CTD was found in complex with full length
~460 kDa PC1 (C). Quantification shows mean values were found to be
statistically different (p=0.0005) using 1-way ANOVA (D).
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GST-OFD1 fusion proteins with or without the CC domains were used to
investigate the importance of OFD1 CC domains for interaction with PC1. GSTOFD1-NTD (44kDa) is comprised of GST fused to the N-terminus of OFD1
containing the LisH motif (Figure 30A). GST-OFD1-CTD (129kDa) consists of
GST fused to the C-terminal portion of OFD1 containing the CC domains (Figure
30A). GST only, GST-OFD1-CTD, or GST-OFD1-NTD purified protein were
incubated with RCTE cell lysate and glutathione beads were used to recover the
GST fusion proteins and any bound proteins from the cell lysates. The
glutathione-bead-bound-proteins were resolved by SDS-PAGE, and
immunoblotted. Probing for GST identified recovery of GST only and both GSTOFD1 fusion proteins (Figure 30B). Probing for full length PC1 (~460kDa)
showed GST-OFD1-CTD containing the CC domains was able to interact with
PC1 but GST-OFD1-NTD and GST alone failed to pulldown PC1 from RCTE cell
lysates (Figure 30C; Quantification: Figure 30D). These data show that the CC
domains of OFD1 are required for OFD1 interaction with PC1 and coupled with
the PC1 CC mutant analyses shown above make it likely that there is a
reciprocal interaction between the CC domains of PC1 and OFD1.
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Chapter 5: Discussion

The data presented here identify the presence of a ciliary signaling complex that
is conserved between cells of kidney tubules and the oral cavity. I show that this
complex consists of the polycystins (PC1 and PC2), the OFD1 ciliopathy disease
gene product, the EGFR receptor tyrosine kinase and the membrane raft
organizing flotillin proteins. Moreover, I demonstrated that when one of these
proteins is mutant it changes the assembly or stability of the entire ciliary
signaling complex in the affected cell types, suggestive of co-assembly into a
common domain. Indeed, the decreased expression of OFD1 in primary cilia
when PC1 is mutant offers a molecular basis for some of the common
pathologies of OFD1 and ADPKD.

The demonstration that the flotillins localize to primary cilia of renal epithelia and
odontoblasts and flotillin-2 interacts with the polycystins, EGFR and OFD1 in
both cell types is extremely exciting for several reasons. The presence of the
flotillins in cilia supports previous speculation regarding commonalities between
basolateral membrane, immune synapse and cilia membrane organization
[47,123,124]. Flotillins are important in the formation of ordered membrane
domains in hematopoietic cells where they are critical for cell polarization and
lymphoid immune synapse formation [96,125,126]. In polarized Madin-Darby
canine kidney cells, both flotillin-1 and -2 have a non-polarized distribution.
Additionally, the flotillins were suggested to have a role in polarization that is
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restricted to hematopoietic cells [125]. However, as we showed in human renal
epithelial cells flotillins bind cholesterol and organize the polycystins, E-cadherin,
tyrosine kinases and phosphatases at the lateral membrane [98]. As shown in
this work, flotillins may also organize the polycystins, EGFR and OFD1 in primary
cilia into specialized domains. The fact that ciliary EGFR levels were less
compromised than the other components is interesting and suggests that the
tyrosine kinase may move in and out of cholesterol based raft domains organized
by flotillins and that this is likely to have functional importance in regulating ciliary
signaling.

Flotillins play a major role in the fidelity of cell signaling and EGFR function
[80,127,128]. Knockdown of flotillin-2 disrupts localization and phosphorylation of
EGFR and activation of downstream MAPK signaling components [100].
However, in breast cancer cells with mutant PIK3CA, a well-known downstream
target of EGFR signaling, knockdown of flotillin-1 causes an upregulation of
EGFR and hyperactivation of MAPK signaling. These data indicate that the
flotillins have dual roles in enabling receptor tyrosine kinase activation and
downstream signaling, as well as in restraining signaling components such as
PIK3CA in an inactive state [129]. Furthermore, the polycystins have been shown
to interact with both receptor tyrosine kinases and phosphatases within primary
cilia [87, 99]. The importance of ciliary organization of EGFR signaling is further
reinforced by recent studies showing that when cilia are ablated, EGFR mediated
activation of apical calcium channels is increased 64-fold [130]. Similarly, in
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IMCD-3 cells, primary cilia were found to restrain interaction and cross-talk
between G-protein coupled receptors, which are also known to cross-talk with
receptor tyrosine kinases [110,131]. Hence, it appears likely that the flotillins
have an important role in the control of ciliary signaling that extends beyond a
purely scaffolding function. Notably, the upshift in molecular weight of flotillin
proteins in the complex is suggestive of post-translational modifications that may
be important in their regulation of specific signaling events.

In addition to EGFR, there are growing numbers of receptor tyrosine kinases
identified in primary cilia of epithelia, neuronal cells and fibroblasts [110]. Of
particular interest are the expression of RON kinase in motile cilia of airway
epithelia and the documented cooperation between EGFR, RON and Met [132134]. Emerging data from studies in human embryonic kidney cells and in breast,
lung and colorectal cancer cells indicate that the RON kinase interacts with
EGFR and may contribute to direct transcriptional regulation [135,136].
Counterbalancing the activities of receptor tyrosine kinases are receptor protein
phosphatases, with members of the LAR family shown to be present in cilia of
renal epithelia [99]. Additional regulation may occur at the level of proteasomal
degradation at the ciliary base [136]. The connections between RON, Met and
EGFR are intriguing because both Met and EGFR are pivotal in cystogenesis
[137-139]. Based on the fact that the decreased levels of OFD1, PC2 and
flotillins were more significantly affected than EGFR in cells expressing mutant
PC1, it is possible that OFD1, PC2 and the flotillins are highly dependent on

112

functional PC1 for ciliary delivery and stabilization whereas EGFR may arrive at
the primary cilium independently of PC1 but relies on functional PC1 for
integration into ciliary signaling protein assemblies.

There are two molecular explanations for the finding that mutant PC1 results in
reductions of OFD1 and other key signaling proteins in primary cilia that
immediately come to mind. First, PC1 and OFD1 may have interdependent roles
in the ciliary transport and/or targeting of the proteins in the complex. Second,
PC1 may be essential for stabilizing the complex within the ciliary membrane.
The data presented here demonstrate that localization and/or stable expression
of OFD1 in primary cilia is dependent on PC1 ciliary localization. From what we
have learned from past studies, there appears to be an ordered sequence of
events for ciliary protein trafficking. First, integral membrane ciliary cargo is
sorted in the Golgi, followed by vesicle budding, translocation to the base of the
primary cilia, docking at the basal bodies, and subsequent vesicle fusion for
incorporation into the ciliary membrane [118,140-142]. Our previous studies on
the ciliary trafficking of the polycystins demonstrated that PC1 is dependent on a
conserved VxPx motif, which is recognized by the small GTPase Arf4 at the
Golgi, for targeting to the ciliary membrane. Truncation of the PC1 C-terminal tail
containing the VxPx motif disrupts the ability of Arf4 to bind PC1 and negatively
affects PC1 localization to primary cilia. The data shown here suggests that
OFD1, a soluble protein that does not have a VxPx ciliary targeting motif,
depends on an interaction with PC1 for localization to the primary cilia. GFP-
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OFD1 localized to primary cilia in cells expressing iDimerize-CD16.7-PC1-WT
but was lacking in cells expressing the iDimerize-CD16.7-PC1-359 VxPx mutant.
Additionally, GFP-OFD1 failed to localize to cilia in cells where iDimerizeCD16.7-PC1 was accumulated in the ER or Golgi. Our previous studies show
that in renal epithelial cells mutant PC1 protein lacking the VxPx motif
accumulates in the Golgi, with possible backup in the ER [43], which suggests
that the absence of ciliary targeting signals causes mutant PC1 to fail to be
properly escorted out of the Golgi. The ciliary trafficking of endogenous wild-type
PC1 may be negatively affected by the accumulation of overexpressed PC1
constructs intracellularly in the ER or Golgi. Native PC1 may oligomerize with
overexpressed iDimerize-CD16.7-PC1 at these intracellular locations resulting in
the inability of endogenous PC1 to facilitate OFD1 ciliary delivery and/or
stabilization. This speculation is supported by our previous studies showing
accumulation of mutant PC1 in the Golgi of ADPKD cystic epithelia results in
dysfunction of basolateral cellular trafficking, which shares numerous similarities
with ciliary trafficking [143]. I show here that GFP-OFD1 co-localized with
iDimerize-CD16.7-PC1 intracellularly when PC1 is accumulated in the Golgi. This
suggests that OFD1 may be recruited with PC1 to the Golgi for delivery to
primary cilia and may explain why GFP-OFD1 failed to traffic to cilia in cells
where PC1 was lacking in primary cilia.

The fact that loss of ciliary PC1 led to decreased OFD1 localization to the ciliary
shaft suggests that PC1 interaction with OFD1, likely via CC domains found in
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both proteins, may be required for ciliary delivery or stable association of OFD1
within the ciliary membrane. Support for this speculation is provided by previous
reports showing PC1 and PC2 also contain CC domains that mediate their
interaction, and are important for their ciliary localization [144,145]. These studies
show that OFD1 interaction with PC1 is dependent on CC domains. Furthermore,
GFP-OFD1 localizes to primary cilia of normal RCTE cells [60]; however GFPOFD1 failed to localize to primary cilia of cells expressing a CC mutant of PC1.
The fact that endogenous PC1 expressed in these cells was not sufficient to
stabilize OFD1 in primary cilia suggests that the overexpressed CD16.7-PC1L152P CC mutant may have a dominant negative effect on OFD1 ciliary
localization. Further characterizing the molecular basis for the interaction
between membrane proteins (such as polycystins) and soluble proteins (such as
OFD1) en route to primary cilia and within the ciliary shaft will be important to
distinguish the role(s) of PC1 in transport and/or stabilization of other ciliary
proteins.

OFD1 has known functions at the base of cilia to control ciliogenesis.
Furthermore, OFD1 may be involved in vesicle docking machineries and
recruitment of intraflagellar transport (IFT) proteins at the base of the cilium.
IFT88 is a crucial component of the IFT complex B, which is involved in moving
proteins along the ciliary axoneme and is required for primary cilia formation. The
CC domains of OFD1 are crucial for the recruitment of IFT88 to centrosomes and
loss of either OFD1 or IFT88 results in failure of cells to produce cilia
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[36,63,71,88,89]. OFD1 plays an important role at the centrosome to control
centriole distal appendage formation and to stabilize centriolar microtubules at a
defined length [63]. Distal appendages are also implicated in the trafficking and
docking of ciliary vesicles carrying membrane constituents [146-149]. It is
possible that OFD1 is involved in the docking of vesicles containing ciliary
membrane proteins such as PC1 and simultaneously facilitating interactions with
IFT88 for transfer along the ciliary shaft. In the process, PC1 transfer to cilia may
enable OFD1 entry and/or stabilization. If ciliary vesicle docking at the distal
appendages requires an interaction between PC1 and OFD1, it is conceivable
that the ciliary localizations of multiple components of a preassembled complex
would be similarly affected. Thus, the diminished OFD1 localization to cilia when
PC1 is mutant may adversely affect both ciliogenesis and ciliary function based
on the dual roles OFD1 has in regulating intraflagellar transport components and
membrane vesicles.

In these studies, I show the existence of a protein complex containing the
polycystins, flotillins, EGFR and OFD1 in cilia of both renal and dental cells
providing evidence for the existence of conserved ciliary signaling microdomains
in multiple cell types that may account for the shared pathologies. Furthermore, I
show that the stabilization of OFD1 in the ciliary membrane is dependent on
interaction with PC1, which is facilitated by CC domains found in both proteins.
These data show that when PC1 is mutant, the ciliary localization of PC2, EGFR,
the flotillins, and OFD1 are concomitantly decreased. The requirement of PC1 for
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the ciliary trafficking of OFD1 and integrity of the ciliary microdomain provides a
plausible molecular rationale for the similarities between craniofacial disorders
and cystic kidney disease. These findings provide a molecular explanation for
some of the observed commonalities in the pathogenesis of multi-organ
ciliopathies such as OFD1 and ADPKD and inform strategies for the
development of potential therapeutic interventions that stabilize protein
complexes.
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Future Directions

OFD1 and ADPKD share many similarities in cystic kidney disease
pathogenesis, yet the molecular basis for these commonalities is just beginning
to be unraveled. Experiments investigating how key ciliary signaling proteins
interact will be essential to gain information about the mechanisms by which
overlapping signaling pathways intersect to result in shared disease phenotypes.
The iDimerize-CD16.7-PC1 constructs will allow us further dissection of the
sequence of events involved in OFD1 ciliary protein targeting, docking, and
microdomain assembly in the primary cilia. For example, the system can be used
to identify specific trafficking machinery components important for transport and
will allow immunoprecipitation of complexes that form discrete subcellular locales
during transport. The studies will provide us new and vital information on the
sequence of events involved in the spatiotemporal assembly and delivery of
ciliary OFD1. The present work suggests that OFD1 and PC1 first interact at the
Golgi for delivery to primary cilia. However, further studies should utilize the Golgi
lock experiment combined with subsequent release to primary cilia to determine
whether OFD1 and PC1 first interact at the Golgi, basal bodies at the base of the
cilium, or after both proteins are integrated into the ciliary membrane. The use of
the iDimerize constructs will pave the way for the identification of the cohort of
proteins that are also delivered via the same pathway and the sequence in which
they join the assembly. The present studies lay the groundwork for how receptor
tyrosine kinases may be organized in cilia and warrant an expanded
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characterization to determine how receptor protein kinases and phosphatases
along with other signaling proteins may interact with or be co-assembled with the
flotillin-EGFR-polycystin-OFD1 protein complexes characterized here.

Establishing the flotillins as critical organizers of ciliary microdomains will set the
stage for analyzing the role of the flotillins in the coordinated transport of
associated proteins to cilia. The importance of the flotillins in immune synapse
formation, which is dependent on highly targeted membrane protein insertion,
suggests that they are likely to play a similarly pivotal role in ciliogenesis through
their interactions with OFD1 and the polycystins. I hypothesize that OFD1
associates with flotillin-organized ciliary microdomains enabling stabilization of
this cytosolic protein in specialized areas of the cilia. The flotillin proteins contain
cholesterol binding CRAC domains that are important for flotillin binding
cholesterol to organize lipid raft domains. Future studies using methyl cyclodextrin (known to disrupt flotillin protein assemblies of PC1) will determine
how cholesterol depletion will disrupt the OFD1 ciliary microdomains organized
by the flotillins. Alternatively, flotillin siRNA knockdown could be used to
investigate the effect on OFD1, PC1, PC2, and EGFR ciliary localization and
interactions. I predict that the reduction in flotillins will impair ciliary microdomain
formation and disrupt OFD1 ciliary localization.

The delivery of proteins to the primary cilium relies on variety of trafficking
chaperones and machinery to arrive at this destination. Because the iDimerize-
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CD16.7-PC1-359 VxPx mutant caused a significant impairment in the trafficking
of OFD1 to the primary cilium, it should be investigated whether or not OFD1
also depends on the small GTPase Arf4, which recognizes the VxPx motif in
PC1, for transport to the cilium using Arf4 siRNA. Significant decreases in cellular
Arf4 should cause a significant reduction in the amount of OFD1 present in the
cilium if transport depends on PC1. In the event that PC1 is not required for
OFD1 ciliary delivery, we predict that OFD1 traffics to the basal body and cilium
via an alternative route, likely through interaction with the IFT-B complex.
Alternatively, because OFD1 has been shown to recruit the intraflagellar
transport protein IFT88 to the base of the cilium, there exists the possibility that
OFD1 is a chaperone in this pathway and may be responsible for docking
polycystin-containing vesicles at the base of the cilium instead of co-trafficking
with PC1 from the Golgi. Polarized RCTE cells transfected with siRNA against
OFD1 to deplete OFD1 protein will allow analysis of OFD1 functions distinct from
those described to be important for ciliogenesis, and will help dissect if PC1 may
also rely on OFD1 for ciliary delivery.

The important role of OFD1 in regulation of primary cilia is supported by the
finding that OFD1 co-localizes with other ciliopathy disease proteins at centriolar
satellites including BBS4 and CEP290 [34]. At this cellular location, OFD1
interacts with the key centriolar satellite component PCM-1 via the CC domains
of OFD1. The CC domains 2 through 4 of OFD1 are crucial for the recruitment of
IFT88 to centrosomes. At this cellular location, OFD1 interacts with the key
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centriolar satellite component PCM-1 via the 5th CC domain of OFD1. This
finding supports the functional importance of the various CC domains found in
OFD1 and suggests that OFD1 mutations that affect different domains may
contribute to clinically diverse phenotypes. This is evidenced by the observation
that in human patients, OFD1 CC mutants were associated with tooth
abnormalities, while splice variants were associated with kidney disease [150].
Furthermore, mutations predicted to affect the extreme C-terminus of OFD1
including the 5th CC domain are found in rare male patients with mental
retardation and digital abnormalities [34]. Further studies on which CC domains
of OFD1 are required for interaction with PC1 will be essential to dissect how
these proteins are assembled into ciliary microdomains together.

In summary, further studies to determine how OFD1 and PC1 interact en route to
primary cilia and how they are assembled into ciliary microdomains will be an
important next step in these studies. Additionally, the trafficking machinery
required for OFD1 ciliary delivery has yet to be determined. The flotillins role in
the assembly of ciliary signaling domains will be important to establish how these
unique microdomains are organized and how disruption of these domains results
in human diseases with multi-organ pathologies.
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